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ABSTRACT 
 
 
DAVID G. STERKA JR. Intracellular pattern recognition receptors underlie 
inflammatory responses of glial cells to central nervous system pathogens. (Under the 
direction of DR. IAN MARRIOTT) 
 
 
 There is growing appreciation that the resident glial cells of the CNS, in particular 
microglia and astrocytes, are important participants in the generation of inflammation 
during brain infection.  However, the mechanisms by which these cell types perceive and 
respond to microbial pathogens is only recently becoming apparent with the discovery of 
highly conserved families of pattern recognition receptors.  In the current study we 
demonstrate that microglia and astrocytes express members of the NOD-like family of 
intracellular receptors. We demonstrate that the NOD2 pathway represents a fu ctional 
mechanism by which these cells can augment the responses mediated by otherfamilies of 
pattern recognition receptors, specifically members of the Toll-like receptor family.  
Furthermore, we show that the NOD2 pathway contributes to the generation of 
potentially damaging inflammation in response to N. meningitidis and B. burgdorferi, 
both in vitro and in vivo, and that the elimination of this pathway results in a decrease in 
the production of important inflammatory mediators. Our additional studies involving 
viral infection of microglia and astrocytes highlight the potential of these cell typ s to 
respond to a variety of microbial types. Additionally, this work also demonstrated he 
replication-dependent nature of glial responses to vesicular stomatitis virus, a model of 
rabies, which points to the use of replication-dependent intracellular receptors such a Rig-
I. Taken as a whole, this study implicates intracellular pattern recognition receptors as 
potentially important contributors to the glial immune responses within the CNS.
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CHAPTER 1: INTRODUCTION 
 
 
Bacterial infection can cause damaging inflammation within the central nervous  
system (CNS) 
 
Traditionally the central nervous system is considered an area of the body that is 
largely devoid of immune response, a state referred to as “immune privileged”.  Such an 
outlook is supported by observations of poor immune response generation in allograft 
tissue implantation experiments as compared to other possible sites (Cserr and Knopf 
1992).  This concept is further supported by the presence of the selective blood-brain 
barrier, relatively low expression of immune molecules, and absence of convential 
lymphatic drainage (Barker and Billingham 1977; Nathanson and Chun 1989).  The 
benefits of immune privilege within the CNS are quite obvious in that an immunological 
response in this area has the potential to be more devastating than the agent causing he 
response (Brent 1990).  As such, it was classically believed that the CNS is isolated from 
the immune system.  In this model, innate immune responses are severely impaired as the 
afferent arm of the adaptive immune response is disrupted by the lack of convential 
lymph drainage, preventing the movement of antigens to the lymph nodes, while the 
efferent arm is disrupted by the blood-brain barrier which prevents the movement of 
effector cells into the CNS (Barker and Billingham 1977; Leibowitz and Hughes 1983).   
Recent studies suggest that previous assumptions concerning CNS immune 
responses were not entirely accurate.  While the CNS can be considered immune 
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privileged, it is still under constant immune surveillance (Hickey 2001).  Immune activity 
observed in resident cells provides strong evidence that innate immune responses are 
generated with the CNS.  Indeed, studies have demonstrated that some resident cell types 
can be induced to express important inflammatory mediators (Dong and Benveniste 
2001; Kielian 2004b).  Rapid responses by these cells may set the stage for potent 
adaptive immune response (Schwartz et al. 1999).  While the blood-brain barrier does 
present a formidable obstacle to effector cell migration into the CNS, it is far from 
impenetrable.  Indeed, very low levels of adhesion molecules are constitutively expressed 
by the endothelial cells of the blood-brain barrier and leukocytes are able to utilize these 
molecules to traverse the barrier (Bart et al. 2000).  Likewise there is an inherent level of 
immunoglobulin G (IgG) present in cerebrospinal fluid as a result of molecule migration 
(Bart et al. 2000).  During a disease state the blood-brain barrier changes mark dly.  
These changes are believed to be a result, in part, of rising levels of tumor necrosis factor 
alpha (TNF-α), an important pro-inflammatory cytokine.  Following exposure to TNF-α, 
the permeability of the blood-brain barrier increases dramatically, resulting in ncreased 
leukocyte migration as well as movement of molecules into and out of the CNS.  
Interestingly, the source of TNF-α need not be local, as rising levels within systemic 
circulation produce similar effects (Fabry et al. 1995; Mark and Miller 1999; Dickstein et 
al. 2000).  As such, the blood-brain barrier does not impede the efferent arm of the 
immune response, but instead closely regulates the movement of effector cells into the 
CNS.  Likewise, the afferent arm of the immune response is not impeded as much as 
previously supposed.  While the CNS does lack conventional lymphatics, the role of 
these passages is accomplished via other means.  Specifically, the movement of 
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cerebrospinal fluid in the brain and the Virchow-Robins spaces allows for the drainage 
into typical lymphatics, which are located along the cranial and spinal nerves (Cs rr et al. 
1992; Kida et al. 1995).  Therefore, these observations of cell trafficking, a lymph-like 
system, and immune activity in endogenous glial cells have provided evidence that the 
CNS is more immunocompetent than originally believed. 
Interestingly, the immunocompetent nature of the CNS is not as beneficial in 
some disease states as one would suppose.  The immune response, while at times 
protective, can also cause collateral damage in areas of infection.   In the case of
inflammation in the CNS, it has been documented that the inflammatory response 
mediates damage in a variety of disease states.  The initiating agentsof this inflammation 
are variable and can be of both bacterial, such as brain abscess, Lyme disease, and 
bacterial meningitis, or non-bacterial in origin as observed in Alzheimer’s disease, 
multiple sclerosis, allergic encephalomyelitis, and HIV-associated dementia.  However, 
in all of these situations the major source of CNS damage is more likely to be the 
inflammatory response than the source of antigen directly (Benveniste 1997b; Gonzalez-
Scarano and Baltuch 1999; Stoll and Jander 1999; Kielian 2004b; Kielian 2004a; Streit 
2004).  The presence of bacteria within the CNS is especially problematic and in most
cases, if left untreated, results in the death of the host (Rajnik and Ottolini 2000).  
Luckily, the blood brain barrier provides protection against most bacterial types 
(Nathanson and Chun 1989). However, some neurotropic bacteria are specially adapted 
to cross this barrier and establish infection (Kim 2006).  The nutrient-rich cerebrospinal 
fluid provides an ideal growth medium for bacterial proliferation.  The detection of 
bacterial antigens by resident cells causes the generation of an innate immune response.  
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This results in the production of pro-inflammatory molecules including cytokines and 
chemokines which serve to both amplify the immune response and draw in additional 
immune cells from the periphery (Van Wagoner and Benveniste 1999; Ambrosini and 
Aloisi 2004; John et al. 2005).  While these responses serve to help control the magnitude 
of infection, there is also collateral damage to the delicate cell types within the CNS 
directly through the production of cytotoxic effects by immune cells as well as indirectly 
through pressure caused by brain swelling (Gasque et al. 1995; Medana et al. 2000; Nau 
and Bruck 2002).  This, coupled with the limited regeneration of CNS cells, can result in 
permanent neurologic deficit (Bailey et al. 2006).   
Borrelia burgdorferi and Neisseria meningitidis are important Gram-negative  
bacterial pathogens of the CNS 
 
Borrelia burgdorferi, the causative agent of Lyme disease, is a Gram-negative 
spirochetal bacterium transmitted by Ixodes ticks (Magnarelli and Anderson 1988).  
Infection with this bacterium is the most recognizable arthropod-borne infection in the
United States (Kaiser 1998).  Approximately 15% of untreated exposures result in a 
crossing of the blood-brain barrier leading to neuroborreliosis, a degenerative condition 
of the central nervous system (Steere 2001).  This infiltration, along with other evasion 
strategies such as antigenic variation, regulation of antigen expression, and suppres ion 
of immune action, provides a means by which to circumvent the immune responses of the 
infected host (Embers et al. 2004).  Furthermore, B. burgdorferi can associate and invade 
neuronal and glial cells which further contributes to the survival of this bacteria in the 
CNS (Livengood and Gilmore 2006).  Neuroborreliosis manifests itself clinical y through 
encephalitis, cranial neuropathy, and meningitis.  Although the neurological symptoms 
are variable, patients commonly develop cognitive and memory impairment during the 
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course of infection, which may or may not resolve with clearance of the bacteria 
(Halperin 1997).  This is because the inflammation associated with this condition results 
in debilitating effects including cell damage and death of neurons within the central and 
peripheral nervous systems (Steere 2001).  Studies have shown that B. burgdorferi can 
cause robust innate immune responses within the CNS as evidenced by rapid local 
increases in important pro-inflammatory mediators such as IL-1, IL-6, TNF-α, and nitric 
oxide (NO) and chemokines such as MCP-1, MIP-1α, and MIP-1β (Habicht et al. 1985; 
Defosse et al. 1992; Tatro et al. 1994; Isogai et al. 1996).  Additionally, increases in glial 
fibrilliary acidic protein and TNF-α in cerebral spinal fluid are observed during infection 
(Dotevall et al., 1996; Widhe et al., 2002).  These important innate immune responses 
serve to direct adaptive immunity as well as amplify the overall inflammtory response 
through the migration, proliferation, and maturation of innate immune cells. 
Neisseria meningitidis, another bacterial pathogen of the CNS, is one of the three 
most common causes of bacterial meningitis which, despite antimicrobial treatment, is 
one of the top 10 infectious causes of death worldwide (Scheld et al. 2002).  This Gram-
negative diplococcal bacterium exists within the nasopharynx of close to 40% of the adult 
population as a member of the normal flora and is spread via respiratory secretions.  In 
order to cause disease this bacterium must colonize the nasopharynx, traverse into the 
bloodstream, evade the host immune mechanisms of the intravascular space, cross the
blood-brain barrier, and replicate in the subarachnoid space (Tzeng and Stephens 2000).  
N. meningitidis is able to cross the epithelial barrier in the nasopharynx as well as the 
blood-brain barrier through pili-mediated adhesion to CD46 molecules (Johansson et al. 
2003).  After penetration this pathogen has been shown to proliferate both extracellularly 
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as well as within resident cells of the CNS (Nikulin et al. 2006).  This infection of the 
CNS can result in the impairment of cerebrospinal fluid dynamics, formation of brain 
edema, increased intracranial pressure, arterial and venous cerebral vascular defect, 
seizure activity, other neurologic sequelae, and death (Nathan and Scheld 2000).  
Damage to the CNS is manifested predominantly as necrotic cortical injury and apoptotic 
hippocampal injury (Pfister et al. 1994; Braun et al. 1999; Nau et al. 1999).  In spite of 
bacterial clearance, 30-50% of survivors will retain some type neurologic deficit 
(Grimwood et al. 2000).  Obviously, the host immune response is not able to control the 
infection within the CNS and it is believed that the immune response is responsible for 
many of the damaging events during this disease state (Tunkel and Scheld 1995; Pfister 
and Scheld 1997).  Indeed, as with B. burgdorferi, robust innate immune responses are 
generated within the CNS.  Copious amounts of pro-inflammatory mediators, such as IL-
1, IL-6, TNF-α, and NO, and chemokines, such as IL-8, MCP-1, MIP-1α, MIP-2, and 
MIP-1β are produced by resident cell types (Leib et al. 1996; Spanaus et al. 1997; Lahrtz 
et al. 1998; Winkler et al. 2001).  The chemokines serve to stimulate the immigration of 
leukocytes to the location of CNS infection while the cytokines amplify the inflamm tory 
responses of both resident and infiltrating cells.  The effector functions of these cells, 
such as the production of reactive oxygen species, have been implicated as a major 
source of damage during bacterial meningitis (Tunkel and Scheld 1995; Leib et al. 1996; 
Pfister and Scheld 1997).  However, these responses lack the ability to clear the pathog n 
from the CNS. This is likely due to the immune evasion mechanisms of this pathogen 
including immunomodulation, resistance to phagocytosis, antibody cleavage, and 
intracellular invasion (Dehio et al. 2000). 
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While Borrelia burgdorferi and Neisseria meningitidis are highly disparate 
organisms, they are both significant pathogens of the CNS which result in high risk of 
morbidity and mortality regardless of the available treatment options (Halperin 1997; 
Scheld et al. 2002).  The damage resulting from infection by these organisms is mediated, 
in large part, by the host immune responses.  Indeed, while the immune responses serve 
to limit bacterial proliferation they also result in damage to the delicate cell types of the 
CNS (Tunkel and Scheld 1995; Pfister and Scheld 1997; Steere 2001).  As such, the 
study of these pathogens and the immune responses generated against them is an 
important undertaking.  Beyond this, both of these pathogens have the unique ability to 
invade and survive within the resident cells of the CNS, including microglia and 
astrocytes. This behavior is particularly interesting in that it limits the perception of these 
pathogens by immune cells as well as limits their exposure to mechanisms of immune-
mediated clearance (Dehio et al. 2000; Livengood and Gilmore 2006).  
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Resident CNS cells contribute to the generation of potentially damaging  
inflammation 
 
  Microglia are considered to be the facultative macrophages of the central nervous 
system (Jordan and Thomas 1988; Aloisi 2001).  The specific phenotype of these resident 
cells is indicative of specialized adaptation to the neural environment, as they exhibit a 
“down-regulated” phenotype in their normal state unlike that of other macrophage 
populations, this phenotype is characterized by low expression of CD45 and other surface 
molecules coupled with lack of phagocytic and endocytic properties (Perry and Gordon 
1988; Kreutzberg 1996).  The role of this cell type in the normal brain is largely unknown 
although evidence suggests that they may have homeostatic and reparative functions 
(Kreutzberg 1996; Batchelor et al. 1999).  In response to trauma or infection, Microglia 
quickly activate and undergo rapid cell proliferation known as reactive microgliosis 
(Streit et al. 1999; Wirenfeldt et al. 2005).  This rapid proliferation is in stark contrast to 
the normal slow turnover of microglia usually occurring in the CNS (Lawson et al. 1992).  
In addition, microglia become activated at the site of challenge, enlarge, and assume 
many of the immune effector functions typically associated with macrophages.   In this 
respect, they are able to contribute to the establishment of non-specific inflammation as 
well as adaptive immune responses.  Microglia gain endocytic and phagocytic activity, 
facilitated by expression of Fc receptors, and the ability to present antigen in the context 
of MHC class II molecules (Hickey and Kimura 1988; Ulvestad et al. 1994; Streit et al. 
1999).  This latter function is supported by the expression of other molecules important in 
antigen presentation, namely CD11a, CD40, CD54, CD58, CD80 (B7-1), and CD86 (B7-
2), which are expressed upon microglia activation (Williams et al. 1994; Cannella a d 
Raine 1995; De Simone et al. 1995; Satoh et al. 1995; Gerritse et al. 1996; Tran et al. 
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1998).  These molecules, in combination with MHC class II, allow microglia to function 
as professional antigen presenting cells for both naïve and memory T-cells.  Indeed, 
although inferior to other types of macrophages, microglia can be considered to be the 
most effective antigen presenting cells within the brain parenchyma (Shrikant and 
Benveniste 1996).   Microglia can be also induced to produce a variety of cytokines and 
chemokines including key pro-inflammatory molecules such as TNF-α, IL-6, IL-12, IL-
1β, MIP-1α, MCP-1, and IL-8 (Kiefer et al. 1993; Meda et al. 1995; Walker et al. 1995; 
Lorton et al. 1996; Meda et al. 1996; Liu et al. 1998; Aloisi et al. 1999; Meda et al. 1999; 
Prinz et al. 1999; Streit et al. 1999; Gregersen et al. 2000; Nadeau and Rivest 2000; 
Owens et al. 2005).  This is of particular importance because chemokines facilitate the 
recruitment of leukocytes into the CNS and cytokines contribute to their subsequent 
activation.  This further highlights the importance of microglia in immune response 
generation since these events are integral to the development and amplification of host 
immune responses. Additionally, microglia can directly mediate damage to other CNS 
cells though production of reactive oxygen species as well as complement components 
(Ulvestad et al. 1994; Akundi et al. 2005). 
 Astrocytes, the major glial cell type in the central nervous system, ar  important 
cells in CNS homeostasis.  These cells influence neuronal function through the releas  of 
neurotropic factors, assist synaptic formation and maintenance, help guide neuronal 
development, contribute to neurotransmitter metabolism, regulate the extracellular 
environment, and contribute to the integrity of the blood-brain barrier (Bush et al. 1999; 
Rubin and Staddon 1999; Sofroniew et al. 1999; Haydon 2000; Dong and Benveniste 
2001; Ullian et al. 2001).  Astrocytes have also been recognized as potentially important 
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contributors to inflammatory immune responses within the brain.  Upon activation 
astrocytes undergo astrogliosis; a rapid proliferation followed by morphological changes 
and increased expression of glial fibrilliary acidic protein (GFAP).  This event can be 
beneficial through the production of neuronal growth factors or it can be damaging, 
resulting in the production of glial scarring and functional impairment (Hatten e  al. 
1991). As with microglia, astrocytes can be induced to express MHC class II molecules 
and can, importantly, process and present antigen in its context (Soos et al. 1998).  
However, the role of astrocytes as a professional antigen presenting cell is still in 
question.  Some studies have reported that astrocytes can be induced to express B7-1 
(CD80), B7-2 (CD86), and CD40 (Nikcevich et al. 1997; Issazadeh et al. 1998; Tan et al. 
1998; Abdel-Haq et al. 1999; Soos et al. 1999).  In contrast, others have reported that 
these cells lack expression of these molecules both constitutively as well as fol owing 
activation (Williams et al. 1994; Satoh et al. 1995; Windhagen et al. 1995; Aloisi et al. 
1998; Cross and Ku 2000; Nguyen and Benveniste 2000; Togo et al. 2000).  As such, it is 
possible that these cells may act as nonprofessional antigen presenting cells, stimulating 
memory T-cells, but not naive T-cells.  Obviously additional research would be required 
in order to better describe the role of astrocytes as antigen presenting cells.  The role of 
astrocytes in the production of inflammatory mediators, however, is well established.  
Astrocytes have been shown to produce a variety of pro and anti-inflammatory cytokines, 
including IL-1, IL-6, IL-10, GM-CSF, G-CSF, M-CSF, TNF-α, and TGF-β, and 
important chemokines, such as RANTES, IL-8, MCP-1, and IP-10 (Benveniste 1997a; 
Owens et al. 2005). As a potent source of both of these molecule classes, which are 
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important mediators of the inflammatory process, astrocytes are integral contributors to 
the development of CNS immune responses.  
 These resident glial cells have been implicated as major contributors to damage-
causing inflammation in disease states including, but not limited to, bacterial infection 
(Boje and Arora 1992; Ulvestad et al. 1994).  They have the capacity to detect and 
respond to pathogens in circumstances lacking infiltrating immune cells and est blished 
inflammation.  The innate immune actions of these cells represent some of the earliest
responses to CNS infection and help set the stage for subsequent inflammatory and 
immune responses (Schwartz et al. 1999; Owens et al. 2005). These responses, while at 
times protective, can also be damaging to the delicate cells of the CNS.  The ability of 
these two cell types to contribute in damaging inflammation is well illustrated in studies 
of CNS disease.  Indeed, studies in HIV-1-associated dementia, Alzheimer’s disease, and 
Multiple Sclerosis highlight the potential of microglia and astrocytes to elicit damage to 
the nervous system (Minagar et al. 2002).  As part of these disease states, microglia and 
astrocytes become activated, proliferate, and assume their effector functions including 
antigen presentation, cytokine and chemokine excretion, and the production of cytotoxic 
molecules (Wisniewski et al. 1989; Tyor et al. 1992; Wesselingh et al. 1993; Giulian et 
al. 1995; Conant et al. 1998). These actions lead to changes in blood-brain barrier 
permeability as well as the recruitment and activation of peripheral immune cells, 
ultimately amplifying the immune response and causing increased inflammation within 
the CNS (Minagar et al. 2002; Bailey et al. 2006). This inflammation, although required 
for pathogen/antigen clearance and damage repair, can also result in collateral d mage to 
 12
the delicate cells present in the CNS such as neurons. Damage to these cells i  
particularly devastating due to limited regenerative abilities.  
Resident CNS cells perceive bacterial and viral pathogens 
 
Recent studies by our group, as well as others, have demonstrated that microglia 
and astrocytes have the ability to perceive and respond to microbial pathogens. These 
resident glial cells have been shown to respond to a variety of bacterial species of both 
Gram-negative and Gram-positive types including Borrelia burgdorferi, Neisseria 
meningitidis, and Staphylococcus aureus (Kielian et al. 2002; Rasley et al. 2002a; Esen et 
al. 2004; Kielian et al. 2004; Rasley et al. 2006; Chauhan et al. 2008).  The activation of 
microglia and astrocytes, however, is not limited to bacterial infections. Studies have 
demonstrated the ability of these cells to respond to multiple viral species and types 
including Borna virus, West Nile virus, vesicular stomatitis virus, Japanese encephalitis 
virus, HIV, Theiler’s, Measles, and rabies (Christian et al. 1996; Marquette et al. 1996; 
Noe et al. 1999; D'Aversa et al. 2004; Cheeran et al. 2005; Ovanesov et al. 2006; So et al. 
2006; Jin et al. 2007; Alvarez et al. 2008; Das et al. 2008; Kang et al. 2008; Lehrmann et 
al. 2008; Ovanesov et al. 2008). Interestingly, bacterial and viral components have been 
shown to be a sufficient stimulus to result in the activation of microglia and astrocytes. 
Investigations of this phenomenon have demonstrated that lipopolysaccharides, flagellin, 
unmethylated CPG motifs, synthetic ssRNA, synthetic dsRNA, and lipoteichoic acids are 
able to elicit the effector responses of these cells, notably cytokine production (Dalpke et 
al. 2002; Jack et al. 2005; Kinsner et al. 2006; Lund et al. 2006; Suuronen et al. 2006; 
Gurley et al. 2008). However, the mechanisms by which these cell types perceive these 
pathogens and pathogen associated molecules are not fully understood.  
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Innate immune cells utilize pattern recognition receptors to perceive microbial  
pathogens 
 
The function of the innate immune response is to identify and respond to invading 
pathogens in an effort to limit proliferation, control their spread, and assist in microbial 
clearance.  These responses are rapid and not specific to particular pathogens.  The 
mechanisms by which immune cells perceive a pathogen and subsequently generate 
inflammation have long been unknown.  However, the recent discovery of receptors for 
molecules produced by microorganisms has shed light on how this occurs.  These 
receptors, known as pattern recognition receptors (PRRs), interact with highly conserved 
microbial structures known as pathogen-associated molecular patterns (PAMPS).  The 
result is the initiation of the innate immune system leading, ultimately, to the 
development of an adaptive immune response.   The presence of these receptors on many 
cell types confers a selective advantage by allowing for rapid development of the l cal 
immune response to pathogens, a fact demonstrated by the highly conserved nature of 
these receptors (Medzhitov and Janeway 1997; Beutler 2004; Beutler et al. 2004; 
Lemaitre 2004).    
The Toll family of PRRs was originally identified in Drosophila, but studies have 
demonstrated that humans and other organisms express receptors of a similar nature 
termed the Toll-like family of PRRs (Anderson et al. 1985; Lemaitre et al. 1996; 
Lemaitre et al. 1997; Rock et al. 1998; Lemaitre 2004).  To date, the Toll-like receptor 
family is the most highly studied of all PRRs and consist of receptors that recognize 
specific PAMPs of microbial pathogens.  Currently 10 Toll-like receptors (TLRs) (TLR1-
10) in humans and 12 TLRs (TLR 1-9 and 10-13) in mice have been identified 
(Medzhitov and Janeway 1997; Akira 2003).  Structurally, these are type 1 
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transmembrane glycoprotein receptors which consist of an intracellular and extracellular 
domain.  The intracellular domain, consisting of a highly conserved Toll-interleukin-1 
receptor (TIR) domain, mediates the interaction between the receptor and downstream 
effector molecules.  The extracellular domain, consisting of a leucine ri h repeat region, 
is responsible for ligand binding (Beutler 2004; Beutler et al. 2004; Hoebe and Beutler 
2004).  These molecules can be located on the cell surface, such as TLRs 1, 2, 4, 5, 6, and 
10, or intracellularly, such as TLRs 3, 7, 8, and 9 (Bowie and O'Neill 2000; Ozinsky et al. 
2000; Hornef et al. 2003; Latz et al. 2004).  TLRs are expressed on many immune cell 
types including macrophages, B cells, dendritic cells, and even specific types of T cells.  
Aside from this, there is also expression on nonimmune cells including epithelial, 
endothelial, and smooth muscle cell types.  Expression of these molecules can be 
constitutive or modulated by the activation, maturation, or differentiation of the specific 
cell types (Visintin et al. 2001; Rehli 2002; Heinz et al. 2003).   
There are many PAMPs which are recognized by members of the TLR family
including lipopeptides (TLR2), double stranded RNA (TLR3), Lipopolysaccharides 
(TLR4), bacterial flagellin (TLR5), single stranded RNA (TLR7 and TLR8), and 
unmethylated DNA CPG motifs (TLR9) (Poltorak et al. 1998; Qureshi et al. 1999; 
Hemmi et al. 2000; Alexopoulou et al. 2001; Hayashi et al. 2001; Barton and Medzhitov 
2002; Akira 2003; Barton and Medzhitov 2003; Girardin et al. 2003d; Takeda et al. 2003; 
Underhill 2003; Travassos et al. 2004).  It is important to note that there may be other 
PAMPs recognized by TLRs that have not yet been described (Akira 2003; Kawai and 
Akira 2006).  Upon binding of the ligand to the extracellular domain, TLRs dimerize and 
undergo conformational changes to associate with important downstream adapter
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molecules (Visintin et al. 2003; Akira and Takeda 2004; Hoebe and Beutler 2004). There 
are a variety of possible adapters including myeloid differentiation primary response gene 
88 (MyD88), MyD88-adapter-like (Mal), (Toll-interleukin 1 receptor (TIR) domain-
containing adapter protein) TIRAP, Toll-receptor-associated activator of inter eron 
(TRIF), Toll-receptor-associated-molecule (TRAM), and Sterile-alpha and Armadillo 
motif containing protein (SARM) (O'Neill et al. 2003).  The varying responses exhibited 
by the different TLRs are dependent upon the combination of adapters recruited upon 
ligation which allows for a tailored response by the cell through the activation of 
specialized inflammatory genes including those controlling the NFκB and MAP kinase 
pathways (Hirschfeld et al. 2001; Gao et al. 2002; Doyle et al. 2003; Nau et al. 2003).   
Microglia and astrocytes express pattern recognition receptors 
 
  Studies have shown that microglia and astrocytes, resident glial cells of the CNS, 
express pattern recognition receptors, namely members of the Toll-like family of 
receptors. Indeed, recent studies conducted by our group as well as others have 
demonstrated that microglia and astrocytes express TLR2, TLR3, TLR4, TLR5, TLR7
TLR8, and TLR9, receptors for lipoproteins, double stranded RNA, lipopolysaccharide, 
bacterial flagellin, single stranded RNA, and unmethylated DNA CpG motifs, 
respectively (Laflamme and Rivest 2001; Bsibsi et al. 2002; Rasley et al. 2002a; 
Bowman et al. 2003; Esen et al. 2004; Olson and Miller 2004; Carpentier et al. 2005; 
Esen and Kielian 2005; Jack et al. 2005; Kielian et al. 2005a). These receptor types are 
constitutively expressed by microglia and astrocytes, which would indicate their use as a 
constant mechanism for immune surveillance. Importantly, the levels of these receptors 
are increased upon activation of microglia and astrocytes. The induction of higher pattern 
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recognition receptor levels has been shown to occur following exposure to their specif c 
ligands, as well as the ligands associated with other pattern recognition recepto s. This 
effect also occurs in response to more complex stimuli including the clinically relevant 
bacteria N. meningitidis and B. burgdorferi. The presence of these receptor types within 
these resident glial cells is consistent with the profile of microbial component responses 
observed in these cell types, which provides an important explanation for the mechanism 
of how these responses are mediated. Evidence suggests that these molecules are 
important in the immune activation of these cells types and generation of subsequent 
effector functions, in particular by the induction of cytokine and chemokine production 
(Jack et al. 2005).  
Members of the NOD-like receptor family of cytosolic proteins function as  
intracellular pattern recognition receptors 
 
Recent studies have identified a new family of novel intracellular pattern 
recognition receptions.  Nucleotide binding and oligerimization domain receptors or 
NODs are part of a family of cytosolic protein receptors known as NOD-like receptors 
(NLRS).  This family of receptors contains some members that appear to pl y a role in 
the recognition of bacteria and induction of inflammatory responses (Girardin et al. 2001; 
Carneiro et al. 2004).   The members of this family possess what are known as amino-
terminal effector binding domains, which include caspase recruitment domains (CARDs), 
pyrin domains (PYD), or baculovirus inhibitor of apoptosis domains (BIR).   They also 
contain a central nucleotide-binding oligomerization domain (NOD) and a carboxyl-
terminal ligand sensing domain containing leucine-rich repeats or WD40 repeats (Tanabe 
et al. 2004).   These proteins are structurally related to the nucleotide binding site-
leucine-rich repeat class of plant R gene products that mediate pathogen resistanc  in 
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plants.   The plant proteins both recognize and elicit a defensive response following 
exposure to molecules from pathogenic bacteria (Girardin et al. 2002; Chamaillard et al. 
2003a; Athman and Philpott 2004) Intracellular signaling is accomplished by interactions 
between the effector binding domains and signaling molecules after the oligomerization 
of NOD proteins.   To date ligands consisting of components of peptidoglycan have been 
identified for several of the members of the NOD family, including NOD1/CARD4, 
NOD2/CARD15, and Cryopyrin (Chamaillard et al. 2003b; Girardin et al. 2003a; 
Girardin et al. 2003b; Inohara et al. 2003). NOD1, also known as CARD4, has been 
shown to be an important intracellular receptor of bacterial peptidoglycan components in 
specific subsets of bacteria (Girardin et al. 2003a; McDonald et al. 2005). 
  
Figure 1: Schematic representation of NOD1 protein structure 
 
As shown in Figure 1, NOD1 contains a single amino-terminal CARD domain, a 
nucleotide binding site, and a leucine-rich carboxyterminal region (Inohara et al. 1999).  
Lipopolysaccharide was originally thought to be the ligand for NOD1, but further s udy 
revealed that this finding could be attributed to peptidoglycan contamination of the 
lipopolysaccharide preparation (Inohara and Nunez 2001; Inohara et al. 2001; Yoo et al. 
2002).  Additional studies have also demonstrated the actual ligand to be peptidoglycan 
fragments that contain a specific dipeptide.   This dipeptide is the D-γ-glutamyl-meso-
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DAP (iE-DAP) motif of GM-Tri-DAP and is generated by either degradation of 
peptidoglycan or secretion by the bacteria itself during the process of replication.   The 
iE-DAP dipeptide is found in Gram-negative bacteria and select subsets of Gram-positive 
bacteria (Chamaillard et al. 2003b; Girardin et al. 2003a; Girardin and Philpott 2004; 
Girardin et al. 2005).  This would suggest that the presence of the NOD1 receptor would 
confer an advantage to the host in areas of high exposure to Gram-negative bacteria, such 
as the lining of the intestinal mucosa (Chamaillard et al. 2003b; Girardin et al. 2003a; 
Carneiro et al. 2004; Travassos et al. 2005).  
  
Figure 2: Schematic representation of the NOD2 protein structure 
 
NOD2/CARD15 is also an intracellular receptor, but for a range of bacterial 
peptidoglycan types (Girardin et al. 2003b; Inohara et al. 2003).   As shown in Figure 2, 
there are slight differences in the structural composition between NOD1 and NOD2, as 
NOD2 has two CARD domains (Ogura et al. 2001b; Carneiro et al. 2004).  Defects in the 
gene coding for NOD2 have been implicated in Crohn’s disease, Blau syndrome, and 
sarcoidosis (Hugot et al. 2001; Miceli-Richard et al. 2001; Ogura et al. 2001a).   The 
mutation associated with Crohn’s disease is a result of a frame shift mutation affecting 
the terminal leucine rich repeats and manifests itself as an inability to detect 
peptidoglycan (Ogura et al. 2001a; Girardin and Philpott 2004).  This lack of sensing may 
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result in the lack of a local response to infection leading to systemic respons and 
inflammation (Girardin et al. 2003c; Carneiro et al. 2004).   NOD2 expression has been 
shown to be present in a wide range of cell types including granulocytes, neutrophils, 
dendritic cells, epithelial cells, and myofibroblasts (Gutierrez et al. 2002; Hisamatsu et al. 
2003; Otte et al. 2003).  Like in the studies of NOD1, the stimulation of NOD2 was also 
found to be due to exposure to lipopolysaccharide.  Yet, also as with NOD1, the observed 
stimulation was a result of peptidoglycan persisting through the purification process.   
The actual ligand that initiates activation through NOD2 is muramyl dipeptide (MDP), a 
minimal motif of the peptidoglycan found in both Gram-negative and Gram-positive 
bacteria (Girardin et al. 2003b; Girardin et al. 2003e; Inohara et al. 2003; Travassos et al. 
2004).   In addition studies have shown NOD2 receptors can respond to other structural 
components of peptidoglycan such as muramyl-tri-lys.  However it cannot respond to the 
similar muramyl-tri-DAP (Girardin et al. 2003e; Girardin and Philpott 2004).  Since 
MDP is found in the peptidoglycan expressed on almost all bacterial types it can be
suggested that this molecule serves as a more general receptor than NOD1 for 
peptidoglycan and confers a selective advantage to a host against all bacteria (Gira din et 
al. 2003b; Girardin et al. 2003d; Inohara et al. 2003).  
Since both NOD1 and NOD2 are intracellular receptors, the highly conserved 
peptidoglycan structures in the cell bacterial walls that they recognize must be 
internalized. It is possible that the phagocytic mechanisms of some cell types, such as 
macrophages, are involved. Within the phagosome, bacteria and bacterial structures are 
degraded using a number of lysosomal enzymes. Following degradation, the bacterial 
products, including those recognized by NOD1 and NOD2, may be allowed to come into 
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contact with the cytoplasmic environment of the cell and stimulate these pathways. Some 
of the cell types expressing NOD1 and NOD2, including, but not limited to, intestinal 
epithelial cells, do not undergo active phagocytosis. In such cell types it is possible that 
active invasion of the cell by intracellular pathogens which enter the cyosol results in the 
exposure to the required bacterial products. Another possibility could be that fragments 
of peptidoglycan, released from the replication of extracellular bacteria, are taken up by 
host cells. While these are all viable options for entry of NOD-specific ligands into 
intracellular space, recent studies propose another mechanism. Indeed, studies have 
demonstrated that the molecule hPepT1 has the ability to specifically transpo t muramyl 
dipeptide (Ismair et al. 2006). While the exact mechanisms of NOD ligand transloc tion 
are poorly understood, this opens the possibility that there may be other specific 
transporters to fulfill this role. 
NOD-like receptors can mediate inflammatory responses 
 
Members of the NOD-like family of pattern recognition receptors can contribute 
to the generation of inflammatory responses, in particular those involved with the 
production of inflammatory cytokines.  Studies have demonstrated that the ligands for 
NOD1 and NOD2 can elicit, independently of other stimuli, the production of the 
inflammatory cytokines IL-6, TNF-α, IL-1β, and Il-12 (Adam et al. 1978; Heinzelmann 
et al. 2000; Nau et al. 2002).  Beyond this, NOD ligands have been used as adjuvants for 
antigen-specific T-cell mediated responses and antibody production in that they can 
influence the expression of membrane-bound co-stimulatory molecules important for the
activation of T-cells (Heinzelmann et al. 2000; Nau et al. 2002).  Regardless of their 
differences, both NOD1 and NOD2 utilize the same adapter protein resulting in identical 
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downstream signaling as well as immune response.  Yet this does not eliminate the 
possibility that there may be additional specific responses for each receptor, a feature 
which occurs in the members of the Toll-like receptor family.  Both NOD1 and NOD2 
interact with Rip2 kinase, which is also known as RICK (Rip-like CARD-containing 
kinase) or CARDIAK (CARD-containing interleukin-1β-converting enzyme-associated 
kinase) (Inohara et al. 1999; Ogura et al. 2001b).  
  
Figure 3: Schematic representation of the NOD1 and NOD2 signaling pathway 
As shown in Figure 3, in the resting state the NOD1 and NOD2 proteins are 
negatively regulated by their leucine-rich regions.  While in this state, the leucine-rich 
region is folded to prevent the oligomerization and activation of the receptor pathway.  
However, once a ligand is recognized by the receptor the NOD proteins undergo 
conformational change and become unfolded.  This allows the receptors to become 
oligomerized, which results in the recruitment of Rip2 kinase.   Rip2 kinase contains a 
CARD domain which enables it to physically associate with the oligomerized NOD 
proteins through homophilic CARD-CARD interaction and Rip2 kinase is then able to 
interact with IKKγ, which is a regulatory subunit of the IKK complex, linking these 
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proteins to the IKK complex ultimately results in the activation of NFκB (Inohara et al. 
1999; Ogura et al. 2001b; Kobayashi et al. 2002).  The regulation of NFκB is controlled 
by the binding of inhibitory proteins known as IκB proteins.  The phosphorylation of the 
IKK complex results in the activation of that complex.  This causes the degradation of the 
IκB proteins and results in transcription of the NFκB gene products.  The activation of 
IKK in response to NOD1 or NOD2 activation is best explained by an induced proximity 
model in which the oligomer interacts with the IKKα and IKKβ dimer, thereby increasing 
their proximity and resulting in mutual trans-autophosphorylation (Ali and Mann 2004).  
After activation the IKK complex subunits phosphorylate the IκB proteins.  This 
phosphorylation tags the IκB proteins for ubiquitination and subsequent degradation, thus 
freeing NFκB dimers.  These dimers translocate to the nucleus where they regulate the 
expression of a wide variety of genes, and hence their gene products (Lucas et al. 2004).  
This activation of NFκB is independent of MyD88, which is the key adapter molecule 
involved in signaling via Toll-like receptors (Kobayashi et al. 2002).  There is also d ta 
to suggest that NODs can activate c-JUN N-terminal kinase in response to bacteria, 
however the mechanism is not fully understood (Girardin et al. 2001).  It is important t 
note that there may be other, alternative, adaptor molecules for the NOD2 pathway 
including the recently described GRIM-19.  The pathway for the action of this molecule 
has not been described to date.  However, evidence suggests that this adapter may also 
lead to the activation of the NFκB pathway (Barnich et al. 2005).   
 Studies have shown that the induced expression of NFκB products is a critical 
component in the control of microbial infection and the lack of proper activation results 
in host susceptibility to infection (Ali and Mann 2004).   Liberation and nuclear 
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translocation of the NFκB genes results in the production of important cellular signaling 
proteins.   Important pro-inflammatory cytokines such as TNFα, IL-1, IL-2, IL-6, IL-12, 
TNFα, TNFβ, and GM-CSF are all controlled by NFκB expression.   In addition NFκB 
controls production of chemokines (IL-8, RANTES, MIP-1α, MCP1, and eotoxin) and 
adhesion molecules (ICAM-1, VCAM, E-selectin) (Ali and Mann 2004).  NFκB is 
essential for the production of effector molecules which directly affect pathogens and the 
enzymes which generate reactive intermediates.  Also, NFκB has a role in the 
upregulation of MHC molecules and CD80/86 receptors on the surface of antigen-
presenting cells.  This provides a link between the innate and adaptive immune responses 
facilitating the activation of the adaptive immune response (Lucas et al. 2004). 
Hypothesis and Present Study 
 In the present study we have tested the hypothesis that the immune activation of 
microglia and astrocytes is mediated, at least in part, by novel intracellul r pattern 
recognition receptors of the NOD-like and Rig-like helicase families. This course of 
study is based upon previous observations that microglia and astrocytes, as resident glial 
cells of the CNS, are immunocompetent and the activation of these cell types contributes 
to the potentially damaging inflammation associated with microbial infection. We 
demonstrate that microglia and astrocytes constitutively express members of the NOD-
like family of intracellular pattern recognition receptors, namely NOD1 and NOD2, and 
that the expression of these molecules is increased at both the mRNA and protein level 
following exposure of these cells to N. meningitidis and B. burgdorferi, two disparate and 
clinically relevant pathogens of the CNS. Likewise, this expression is also increased 
following exposure to known Toll-like receptor ligands. However, the expression of 
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NOD1 was markedly lower than that of the NOD2 receptor. This led us to the conclusion 
that NOD2 is potentially a more important receptor in the identification of pathogens by 
glial cells and we focused further studies exclusively on the NOD2 receptor. Importantly, 
both microglia and astrocytes express critical downstream effector molecules for the 
NOD pathways, including RIP2-kinase in astrocytes as well as both RIP2-kinase and 
GRIM19 in microglia. In order to begin to address the functional contributions of this 
pathway in these resident glial cells we demonstrated the ability of NOD2 ligation with 
MDP to significantly augment the production of important pro-inflammatory cytokines, 
namely IL-6, TNF-α, and IL-1β in microglia and IL-6 and TNF-α in astrocytes, following 
Toll-like receptor stimulation. The investigations up to this point provided exciting and 
compelling circumstantial evidence that there is functional expression of the NOD2 
pathway in microglia and astrocytes.  
 In order to confirm our hypothesis and definitively show functional NOD2 
expression, we conducted additional studies. First we demonstrated that there is incr a ed 
association between NOD2 and the downstream effector molecule RIP2-kinase using co-
immunoprecipitation. Following this we performed additional studies utilizing transgenic 
mice deficient in the NOD2 receptor. Experiments mirroring our previous work 
confirmed that wild-type microglia and astrocytes have augmented TLR-mediated 
cytokine production, namely IL-6 and TNF-α, in the presence of MDP. This effect is 
eliminated in cells derived from NOD2-deficient mice. This phenomenon was also 
observed in experiments involving N. meningitidis and B. burgdorferi in which microglia 
and astrocytes derived from NOD2-deficient had significantly lower IL-6 and TNF-α 
production than that observed in wild-type. In-vivo infection studies resulted in similar 
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observations in which the production of pro-inflammatory cytokines was attenuated in 
NOD2-deficent mice. These data provide strong evidence that there is functional 
expression of the NOD2 pathway in microglia and astrocytes and that this pathway may 
be an important contributor to the generation of inflammatory responses by these resident 
glial cells.  
  
Figure 4: Proposed pathway of TLR and NOD2 cooperation in microglia and astrocytes 
 
 Taken as a whole, our data proposes the pathway shown in Figure 4 for glial cells. 
In this model TLR ligands interact with their receptors on microglia and astrocytes 
resulting in the activation of NFκB and the MAP kinase pathways which, in turn, result 
in the production of inflammatory mediators and the upregulation of NOD2 and Rip2 
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kinase expression. The upregulation of members of the NOD2 pathway makes microglia 
and astrocytes more sensitive to levels of MDP and, as the pathway is activated, caus s 
further activation of the NFκB and MAP kinase pathways. This ultimately leads to 
augmentation of inflammatory mediator production beyond that observed with TLR 
ligands alone.  
Our additional studies concerning viral pathogens in microglia and astrocytes are 
based upon research conducted by other members of our group and published in Furr et 
al., 2008. Those studies demonstrated that microglia and astrocytes express members of 
the RIG-like helicase family of pattern recognition receptors. Of particular interest is the 
constitutive expression of RIG-I by these resident glial cells which is upregulated 
following exposure vesicular stomatitis virus (VSV), which is commonly used as a model 
for rabies infection. However, the ability of VSV to infect and replicate within these glial 
cells has not been established. In the present study, we demonstrate that primary murine 
microglia and astrocytes are permissive for VSV infection both in vitro and in vivo.  
Furthermore, we show that active replication of this virus appears to be required for 
robust inflammatory mediator production by these resident CNS cell types.  Th e data 
suggest that viral replication within resident glial cells plays a key rol in the 
development of lethal CNS inflammation following neurotropic Mononegavirus 
infection. Since the RIG-I pathway is only activated during the replication of these
viruses, this provides evidence that stimulation of this pathway may contribute to the 
generation of inflammation by microglia and astrocytes during viral infection.  
Taken in concert, the demonstration of functional NOD2 expression along with 
evidence supporting RIG-I as a mechanism for viral detection provide for a compelling 
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argument that intracellular pattern recognition receptors such as these may play n 
important role in the generation of immune responses by microglia and astrocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2: MATERIALS AND METHODS 
 
 
Wild-Type and NOD2-Deficient Mice 
B6.129S1-Nod2tm1Flv/J mice that are NOD2-deficient (NOD2-/-) and bred for 
>10 generations onto a C57BL/6 background, as well as wild-type C57BL/6j mice, were 
purchased from Jackson Laboratory (Bar Harbour, Maine).  All studies were perform d 
in accordance with relevant federal guidelines and institutional policies regarding the use 
of animals for research purposes 
Reagents and Solutions 
 Lipolysaccharide (LPS; from E. coli, 0.5 and 5 EU/ml) and the muramyl 
dipeptide, MurNAc-L-Ala-D-isoGln (MDP), were purchased from Sigma Chemical 
Company (St. Louis, MO).  The TLR2 ligand, S-(2,3-bis(palmitoyloxy)-(2-RS)-propyl)-
N-palmitoyl-(R)-Cys(S)-Ser-(S)-Lys4-OH, trihydrochloride (Pam(3)Cys), was purchased 
from Calbiochem (San Diego, CA).  An activating oligonucleotide, 
GCTCATGACGTTCCTGATGCTG, previously described as a specific agonist for TLR9 
(Sweet et al. 2002), was synthesized by Integrated DNA Technologies (Coralville, IN).  
Endotoxin-free flagellin protein preparations were isolated from Sal onella typhimurium 
serotype 12023 as previously described (Ibrahim et al. 1985; Bowman et al. 2003).  
Briefly, Salmonella typhimurium serotype 12023 were cultured in a modified medium as 
previously described (Ibrahim et al. 1985).  Salmonella were cultured at 37°C in an 
orbital shaker for 24 h at 200 rpm.  Flagellins were isolated according to the method of 
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Bowman et al. (2003).  Briefly, 500 ml of bacterial culture was centrifuged at 5,000 g for 
30 min and resuspended in 50 ml phosphate-buffered saline.  The suspension was then 
adjusted with 1 M HCl to pH 2.0 and incubated at room temperature with constant 
stirring for 30 min in order to detach flagella.  Bacterial cells were sparated from free 
flagella by centrifugation at 5,000 g for 30 min. Flagellin-containing supernatant was 
then further centrifuged at 100,000 g for 90 min at 4°C to remove pH 2.0 insoluble 
components.  The supernatant was adjusted with 1 M NaOH to pH 7.2 and flagellins 
were precipitated through slow addition of ammonium sulfate to 2/3 saturation (2.67 M) 
with vigorous stirring.  Precipitated flagellins were collected by centrifugation at 15,000 
g at 4°C for 60 min. Pelleted flagellins were resuspended in 5 ml distilled water and 
dialyzed against running tap water for 2 h and then against 1 L distilled water with 10 g 
of activated charcoal for 24 h in Spectrapor dialysis tubing with a molecular weight 
cutoff of 50,000 (Spectrum Medical Industries, Los Angeles, CA).  Flagellin proteins 
were analyzed by 0.1% sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis 
and protein visualized by Coomassie blue staining.  The flagellin isolation procedure 
yielded a single major product with a molecular weight of approximately 48 kDa, a size 
that is within the previously described size range for flagellins from Salmonella serotypes 
(Ibrahim et al., 1985).  Endotoxin was removed from flagellin preparations using a 
Detoxi- Gel endotoxin removing gel column (Pierce, Rockford, IL) according to the 
manufacturer’s instructions.  Residual endotoxin content was determined to be negligible 
according to the Pyrogent Limulus amoebocyte lysate assay (BioWhittaker, Walkersville, 
MD).  Doses selected represent those that were empirically determined to elicit optimal 
responses. 
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Isolation of Primary Murine Microglia 
Murine neonatal brain microglia were isolated and cultured ostensibly as 
described previously (Harry et al. 1998; Rasley et al. 2002a; Rasley et al. 2002b).  
Briefly, six to eight neonatal C57BL/6 mouse brains per preparation were dissected free 
of meninges and large blood vessels and finely minced with sterile surgical scissors.  The 
minced tissue was then forced through a wire screen and briefly incubated with 0.01% 
trypsin–0.005% EDTA for 5 min.  The cell suspension was then washed and this mixed 
glial culture was maintained in RPMI 1640 containing 10% FBS and gentamicin for 2 
weeks.   A microglia culture was obtained from this mixed glial culture by shaking flasks 
for 2 h at 200 rpm in an orbital shaker and allowing the transferred dislodged cells to 
adhere to new tissue culture vessels for 1 h.  The media were then removed and fresh 
RPMI 1640 with 10% FBS and 20% conditioned medium from LADMAC (ATCC 
number CRL-2420) cells as a source of CSF-1 was added to maintain microglia cultures 
for 1 week, as described previously (O'Keefe et al. 2001).  Cells isolated in this manner 
were >95% authentic microglia as assessed by their characteristic morphology and by the 
expression of CD11b and F4/80 as determined by immunofluorescent microscopy 
(Rasley et al. 2002a).   
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Isolation of Primary Murine Astrocytes 
Brain astrocytes were isolated and cultured as described previously (Bowman et 
al. 2003; Rasley et al. 2004a; Rasley et al. 2006).  Briefly, six to eight neonatal C57BL/6 
mouse brains per preparation were dissected free of meninges and large blood vessels and 
finely minced with sterile surgical scissors.  The minced tissue was then forced through a 
wire screen and briefly incubated with 0.01% trypsin–0.005% EDTA for 5 min.  The cell 
suspension was then washed and this mixed glial culture was maintained in RPMI 1640 
containing 10% FBS and gentamicin for 2 weeks.  Astrocyte culture was obtained from 
the mixed glial culture by shaking flasks for 1 h at 210 rpm in an orbital shaker to 
dislodge weakly adherent microglia and these cells were cultured separately s described 
above.  The remaining astrocytes were mechanically dissociated, transferred to new 
tissue culture vessels, and cultured for 1 week prior to use.  Cells isolated in the above 
manner were demonstrated to be greater than 97% authentic astrocytes due to their 
characteristic morphology and the presence of the astrocyte marker, glial fibrillary acidic 
protein (GFAP), and the absence of the microglia cell surface marker, CD11b as 
determined by confocal microscopy (Bowman et al. 2003).   
Culture of Borrelia burgdorferi and Neisseria meningitidis and Preparation of 
Antigen Lysates 
 
 We have utilized B. burgdorferi strain N40 and N. meningitidis strain MC58 in 
these studies. While these organisms are not associated with CNS disease in mice, both 
represent clinically relevant gram-negative bacteria responsible for Lyme 
neuroborreliosis and bacterial meningitis, respectively.  We have previously 
demonstrated that antigens from these organisms elicit robust inflammatory responses by 
both murine microglia and astrocytes (Rasley et al. 2002a; Rasley et al. 2004b; Rasley et 
 32
al. 2006).  Importantly, both of these organisms express peptidoglycan motifs that can be 
recognized by NOD2, but B. burgdorferi lacks the expression of the TLR4 ligand, LPS, 
and has been shown to initiate TLR2- and TLR5-mediated innate immune responses 
(Shin et al. 2008) whereas N. meningitidis expresses LPS and can elicit TLR2- and 
TLR4-mediated responses (Zughaier et al. 2005; Hellerud et al. 2008).   
 A clonal low passage of B. burgdorferi strain N40 was used throughout these 
studies (Barthold et al. 1993).  Spirochetes were grown for a period of two weeks in 
Barbour-Stoenner-Kelly (BSK) II medium at 34°C (Barbour et al., 1984).   N. 
meningitidis strain MC58 was grown overnight (16 hours) in 5 ml of GC medium plus 
hemoglobin with Isovitalex enrichment solution in a shaking water bath at 37oC.   
Bacteria were harvested by centrifugation and washed twice in PBS. Confluent cell 
layers of microglia or astrocytes were washed 3 times with 4 ml of PBS to remove 
growth media and then infected with log growth N. meningitidis or B. burgdorferi at 
multiplicities of infection (m.o.i) of between 3:1 and 30:1 bacteria to cells in media 
without antibiotics for 60 min at 37oC.  Following the infection period, cell cultures were 
washed and incubated in media with 10% fetal bovine serum (FBS) supplemented with 
25 µg/ml gentamicin to kill remaining extracellular bacteria.  At 4-24 hours following 
this procedure, RNA, protein isolates, or culture supernatants were collected.   
 To prepare lysates, log growth B. burgdorferi, N. meningitidis, or S. aureus 
UAMS-1 (ATCC 49230) bacterial cultures were centrifuged at 10,000 X g and washed 
three times with PBS.  Bacteria were then resuspended in PBS and pulsed three times 
with a cell sonicator for 20 seconds at 25 second intervals.   Levels of endotoxin in B. 
burgdorferi antigen isolates were below detectable levels as determined by Limulus 
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amebocyte lysate assay (Cambrex Bio Science, Walkersville, MD) consistent with 
previous reports (Anguita et al., 2002).  The maximum concentration of N. meningitidis 
antigens used (5 µg/ml) contained 1 EU/ml endotoxin as determined by Limulus 
amebocyte lysate assay (Cambrex Bio Science, Walkersville, MD).  Isolated microglia 
and astrocytes were exposed to 1-5 µg/ml B. burgdorferi, N. meningitidis, or S. aureus 
cell lysate as indicated.  Dose ranges used represent those previously determined by our 
laboratory to elicit low to maximal glial responses (Rasley et al. 2002a; Bowman et al. 
2003; Rasley et al. 2006).  At 4-24 hours following this procedure, RNA, protein isolates, 
or culture supernatants were collected. 
Intracerebral Administration of Bacteria 
Viable N. meningitidis or B. burgdorferi (1x106 bacteria) were administered via 
intracerebral (i.c.) injection as previously described by our laboratory (Rasley et al. 2006) 
into NOD2-/- or wild-type mice.  Anesthetized animals were secured in a stereotaxic 
platform and stand and received an i.c. injection containing pathogens 
resuspended in Ringer’s solution (final volume of 1µL), or vehicle only, 1 mm lateral and 
1 mm posterior to the bregma using a Hamilton positive displacement syringe (7001 
series) with a 25-gauge needle and a tubing guard to ensure constant depth of 
administration (3–3.5 mm).  Five animals per group were used and animals displaying 
signs such as seizures, abnormal gait/ataxia, failure to open eyes, or other physical 
disabilities were euthanized immediately.  At 3 days post infection, animals were 
euthanized and all brain tissue removed and weighed.  The brain tissue was mechanically 
disrupted in a glass homogenizer in 3 mL PBS and then centrifuged.  Supernatants were 
analyzed for cytokine content by specific capture ELISA. 
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Isolation of RNA and PCR 
 Poly(A)+ RNA was isolated from microglia and reverse transcribed as previously 
described (Bowman et al. 2003; Rasley et al. 2004a).  Real-time PCR was performed on 
the reverse transcribed cDNA product to determine the expression of mRNA encoding 
NOD1, NOD2, Rip2 kinase, and glyceraldehyde 3-phosphate dehydrogenase (G3PDH) 
essentially as described previously (Marriott et al. 2005).  Positive and negative strand 
PCR primers used, respectively, were GTCCTCAACGAGCATGGCGAGACT and 
AGCTCATCCAGGCCGTCAA to amplify mRNA encoding murine NOD1 (299 bp 
fragment), GCTGCCAATCTTCACGTCGTC and 
TAAGTACTGAGGAAGCGAGACTGA to amplify mRNA encoding murine NOD2 
(273 bp fragment), CTGCACCCGAAGGAGGAACAATCA and 
GCGCCCATCCACTCTGTATTAGA to amplify mRNA encoding murine Rip2 kinase 
(276 bp fragment), and CCATCACCATCTTCCAGGAGCGAG and 
CACAGTCTTCTGGGTGGCAGTGAT to amplify mRNA encoding G3PDH (340 bp 
fragment).  PCR primers were derived from the published sequences of NOD1 
(Strausberg et al. 2002), NOD2 (Iwanaga et al. 2003), Rip2 kinase (Inohara et al. 1998), 
and G3PDH (Tso et al. 1985).  All primers were designed by using Oligo 4.0 primer 
analysis software (National Biosciences Inc., Plymouth, MA) based on their location in 
different exons of the genomic sequences in addition to their lack of significant 
homology to sequences present in GenBank (MacVector Sequence analysis software, IBI, 
New Haven, CT).  The identity of the PCR amplified fragments were verified by size 
comparison with DNA standards (Promega) and by direct DNA sequencing of 
representative fragments (Davis Sequencing, Davis, CA).   
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Co-immunoprecipitation of NOD2 with Rip2 kinase 
Co-immunoprecipitation was performed essentially as described previously by 
(Clark et al. 2001).  Briefly, cells (1x106) stimulated with bacterial lysates were washed 
with ice-cold PBS and lysed at 4°C for 2 h in Tris-buffered saline with EDTA (150 mM 
NaCl, 5 mM EDTA, 20 mM Tris, pH 7.5) plus 1% Brij-97 (Sigma-Aldrich) and 10 
units/mL aprotinin (Calbiochem, San Diego, CA), 1 mM PMSF, and 1 µg/mL pepstatin 
A.  The lysates were incubated with protein A agarose beads (Pierce Endogen) 
conjugated with antibodies directed against NOD2 or Rip2 kinase for 18 h at 4°C.  The 
immunoprecipitated material was subsequently subjected to immunoblot analysis for the 
presence of NOD2 or Rip2 kinase.   
Western blot analysis for NOD1, NOD2, and Rip2-kinase 
Western blot analyses for the presence of NOD1, NOD2, or Rip2 kinase in 
astrocytes and microglia were performed as described previously by our lab ratory 
(Marriott et al. 2005).  Whole protein samples were obtained from microglia, astrocytes, 
and brain tissue in a buffer containing 125 mM Tris base, 20% glycerol, 2% SDS, 1% 
bromophenol blue and 2% 2-mercaptoethanol.  Samples were separated using 10% SDS 
PAGE and transferred to Immobilon-P membranes (Millipore, Bedford, MA).  
Membranes were blocked for 18 hours with 5% skimmed milk at 4°C.  After incubation 
with a rabbit primary antibodies againstNOD1, NOD2, or Rip2-kinase for 24 hours at 
4°C, blots were washed and incubated in the presence of an HRP-conjugated donkey 
anti-rabbit antibody (Cell Signaling, Danvers, MA) or an HRP-conjugated goat anti-
mouse IgG antibody (Sigma-Aldrich, St. Louis, MO).  Bound enzyme was detected with 
the Super Signal system (Thermo Scientific, Rockford, IL).  The primary antibodies used 
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were an affinity purified rabbit polyclonal antibody directed against human NOD1 
(Alpha Diagnostics International Inc., San Antonio, TX), mouse monoclonal antibody 
reactive against mouse NOD2 (Clone 2D9; Novus Biologicals, Littleton, CO), a rabbit 
polyclonal antiserum against human NOD2 (Cayman Chemical, Ann Harbor, MI), and a 
mouse reactive affinity purified rabbit polyclonal antibody directed against Rp2 kinase 
(Cell Sciences Inc., Canton, MA).   
Quantification of IL-6, TNF-α, IL1β, and IL-10 secretion 
Specific capture ELISAs were performed to quantify IL-6, TNF-α, IL1β, and IL-
10 secretion by glial cells as described previously by our laboratory (Anguita et al. 2001; 
Rasley et al. 2004b; Rasley et al. 2006).  TNF-α, IL1β, and IL-10 secretion were 
measured using commercially available ELISA kits (R&D Systems, Minneapolis, MN 
and BD Pharmingen, San Diego, CA).  IL-6 secretion was measured using a rat anti-
mouse IL-6 capture antibody (Clone MP5-20F3) and a biotinylated rat anti-mouse IL-6 
detection antibody (Clone MP5-C2311) (BD Pharmingen, San Diego, CA).  Briefly, 96-
well ELISA plates (ICN Pharmaceuticals, Costa Mesa, CA) were coatd wi h the capture 
antibody (2 µg/ml) overnight at 4°C.  After blocking with PBS plus 10% FBS for 2 h at 
room temperature, samples were applied and incubated for 1 hour at 37°C.  The 
biotinylated detection antibody (1 µg/ml) was added after washing the plates with PBS 
plus 0.5% v/v Tween 20 (PBS/Tween 20).  HRP-conjugated streptavidin was then added 
prior to addition of tetramethylbenzidine substrate (Kirkegaard & Perry Laboratories, 
Gaithersburg, MD) and stop solution (25% v/v sulfuric acid in distilled water).  
Quantification of cytokine levels was achieved by comparison with standard 
concentrations of recombinant mouse IL-6, IL1β, IL-10, and TNF-α (R&D Systems, 
 37
Minneapolis, MN).  Cytokine levels in brain homogenates were normalized to total brain 
weight and reported as pg/g of brain tissue.   
Viral Strains 
Figure 23 shows viral maps of the three recombinant viruses used in this study.  
Recombinant VSV wt (Indiana serotype) and its derivative VSV rHR1-1 with a single aa 
substitution D1671V in the L protein have been previously described (Grdzelishvili et al. 
2005; Grdzelishvili et al. 2006).  To generate heat-inactivated wt-VSV, live virus was 
heated in a water bath at 65°C for 15 minutes.  This procedure was determined 
empirically to eliminate virus replication as determined by plaque assay.  VSV-GFP is a 
VSV wt (Indiana serotype) encoding GFP as an extra gene between G and L ge es (Das 
et al. 2006) and was kindly provided by Dr. Asit K. Pattnaik (University of Nebraska).  
Recombinant wt SeV (Fushimi strain) (Leyrer et al. 1998) and SeV-GFP-Fmut (SeV-
GFP) with an enhanced green fluorescent protein (GFP) upstream of the NP gene 
(Wiegand et al. 2007) were kindly provided by Dr. Wolfgang J. Neubert (Max-Planck-
Institute of Biochemistry, Germany).  Monolayer cultures of Vero or BHK-21 cell lines 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Cellgro) 
supplemented with 9% fetal bovine serum (FBS, Gibco).  To produce VSV or SeV, BHK 
or Vero cells, respectively, were infected with wt or mutant viruses at a multiplicity of 
infection (MOI) of 0.05 plaque-forming units (PFU) per cell in MegaVir HyQSFM4 
serum-free medium (Hyclone) and incubated for 24-48 hr at 34°C.  SeV-GFP virus was 
grown without acetylated trypsin in the medium as they have a wt monobasic trypsn-
dependent cleavage site in the F protein mutated to an oligobasic cleavage site allowing F 
activation in any cell type through a ubiquitous furin-like protease (Wiegand et al. 2007).  
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It should be noted that the MOI values are relative and calculated based on the VSV titer 
determined on BHK cells or SeV titer on Vero cells supporting robust virus replication.  
It is therefore likely that the actual MOI values for microglia and/or astrocytes were 
actually lower than indicated.   
In vitro viral infection 
 Isolated primary microglia and astrocytes were infected with VSV or SeV at MOI 
of 0.001, 0.01, 0.1, 1, and 10 PFU per cell and the virus was allowed to adsorb for 1 hour.  
Non-adherent viral particles were removed by washing with PBS followed by the 
addition of RPMI 1640 media supplemented with 10% FBS (for astrocytes) or 10% FBS 
and 20% LADMAC (for microglia).  Cultures were maintained for 12 and 24 hours prior 
to collection of culture supernatants and preparation of whole cell protein isolates. 
Immunoblot analyses for GFP and VSV products 
Immunoblot analyses for the presence of GFP and VSV proteins in microglia, 
astrocytes, and whole brain samples were performed as described previously by our 
laboratory (Bowman et al. 2003; Rasley et al. 2006).  Whole protein samples were 
obtained from microglia, astrocytes, and brain tissue in a buffer containing 125 mM Tris 
base, 20% glycerol, 2% SDS, 1% bromophenol blue and 2% 2-mercaptoethanol.  
Samples were separated using 10% SDS PAGE and transferred to Immobilon-P 
membranes (Millipore, Bedford, MA).  Membranes were blocked for 18 hours with 5% 
skimmed milk at 4°C.  After incubation with a rabbit polyclonal antibodies against VSV 
or GFP (Thermo Scientific Affinity BioReagents) for 24 hours at 4°C, blots wereashed 
and incubated in the presence of an HRP-conjugated donkey anti-rabbit antibody (Cell 
Signaling, Danvers, MA) or an HRP-conjugated goat anti-mouse IgG antibody (Sigma-
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Aldrich, St. Louis, MO).  Bound enzyme was detected with the Super Signal system 
(Thermo Scientific, Rockford, IL). 
In-vivo viral infection 
 VSV wt or VSV-GFP were administered to 3-4 week old male wt C57BL/6 mice 
(Jackson Laboratories) via intranasal (i.n.) infection essentially as previously described 
by our laboratory (Gasper-Smith et al. 2006).  Anesthetized animals were untreated or 
received i.n. administration of VSV (1 X 107 PFU) in PBS (final volume of 20 ul).  At 5 
days post infection (d.p.i.), protein isolates were prepared from whole brain tissue 
homogenates or mixed glial cells acutely isolated from infected and uninfected animals 
using a modified protocol (Campanella et al. 2002).  All studies were performed in 
accordance with relevant federal guidelines and institutional policies regarding the use of 
animals for research purposes. Infected and uninfected animals were scored 5 d.p.i for
disease severity using protocols previously described by our group (Rettew et al. 2008).  
A score of 1 was given to mice with percolated fur but no detectable behavioral 
differences compared to untreated mice, a score of 2 was given to mice with percolated 
fur and a huddle reflex but were still active, a score of 3 was given to mice that were less 
active and were relatively passive when handled, a score 4 was assigned to inactive mice 
that exhibited only limited response when handled, and a score of 5 was applied to 
moribund mice.  Severity was scored from 1 (no detectable behavioral differences) to 5 
(moribund).  Animals were then euthanized and protein isolates were prepared from 
whole brain tissue homogenates or mixed glial cells acutely isolated from infected and 
uninfected animals as described above.  All studies were performed in accordance with 
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relevant federal guidelines and institutional policies regarding the use of animals for 
research purposes.   
Acute isolation and cytometric analysis of CNS cells 
Mixed CNS cells were acutely isolated from infected and uninfected animals 
using a modified protocol (Campanella et al. 2002).  Briefly, brains were rapidly removed 
and mechanically disrupted in a glass homogenizer, washed, and resuspended in 
PBS/30% Percoll (Fluka, Sigma Aldrich, St Louis, MO) solution.  This was overlaid on a 
gradient containing 37% and 70% Percoll solutions and centrifuged at 600 X G for 20 
min at room temperature.  Glial cells were then collected from the interface and washed 
with PBS.  For VSV-wt infected animals, protein isolates were prepared from the purified 
cells and analyzed for the presence of VSV products by immunoblotting using a 
polyclonal antibody directed against this virus.  For VSV-GFP infected animals, cells 
were stained with an R-phycoerythrin conjugated monoclonal anti-mouse CD11b 
antibody (BD Pharmingen clone #M1-70).  These cells were analyzed using a 
FACSCalibur flow cytometer (Becton Dickson, San Jose, CA) to determine the 
percentage of GFP and CD11b dual positive cells.  A minimum of 50,000 cells were 
counted and data are reported as the percentage of the cell population.   
Fluorescence microscopy 
Fluorescence microscopy pictures were taken using an Olympus DP70 digital 
camera on an Olympus IX71 inverted fluorescent microscope under 10X objective using 
Olympus DP Controller software. 
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Densitometric analyses 
 Densitometric analyses of Western blots were performed using NIH Image 
(obtained from the NIH Web site: http://rsb.info.nih.gov/nih-image).  Results are 
presented as mean values of arbitrary densitometric units corrected for backg ound 
intensity or as fold increases over levels in unstimulated cells. 
Statistical Analyses 
All results are presented as the mean +/- SEM and were tested statistically by 
Student’s t test, one-way analysis of variance (ANOVA) with Tukey’s post h c test, or 
repeated measures ANOVA with Tukey’s post hoc test, as appropriate, using 
commercially available software (Sigma Stat; Systat Software, San Jose, CA). Results 
were considered to be statistically significant at a probability of <0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: EXPRESSION OF NOD2 IN PRIMARY MURINE 
ASTROCYTES 
 
 
3.1 Rationale  
Bacterial invasion of the CNS is well known to result in devastating disease, 
associated with high rates of mortality and morbidity, despite marked advances in 
antimicrobial treatments. Evidence suggests that the often irreversible damage associated 
with CNS infection is mediated in large part not by the pathogen itself, but by the 
immune responses initiated in response to the foreign antigens (Boje and Arora 1992; 
Ulvestad et al. 1994). While the inflammation generated may be protective by limiting 
bacterial proliferation and assisting with pathogen clearance, it also cu es collateral 
damage to the delicate cell types within the CNS (Benveniste 1997b; Gonzalez-Scrano 
and Baltuch 1999; Stoll and Jander 1999; Kielian 2004b; Kielian 2004a; Streit 2004). 
This, coupled with limited generation potential, can lead to permanent neurological injury 
(Gasque et al. 1995; Medana et al. 2000; Nau and Bruck 2002).  
There is growing appreciation that astrocytes, the major glial cell typ  in the CNS, 
are important contributors to the inflammatory immune responses in the brain. Upon 
exposure to inflammatory mediators, bacteria, or bacterial components these cells assume 
effector functions such as the production of cytokines and expression of MHC class II 
molecules which contribute to the recruitment and activation of leukocytes (Hatten et al. 
1991; Benveniste 1997a; Soos et al. 1998; Owens et al. 2005). The mechanisms by which 
these cells perceive and subsequently respond to these stimuli are only recentl becoming 
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apparent with the demonstration of pattern recognition receptor expression, namely thos  
of the Toll-like family of pattern recognition receptors. Indeed, a number of different 
receptors in this family have been shown in astrocytes (Laflamme and Rivest2001; 
Rasley et al. 2002a; Bowman et al. 2003; Esen et al. 2004; Carpentier et al. 2005). 
However, the presence of these molecules does not preclude the possibility of other 
pathways for the identification of pathogens.  
The recent discovery of members of the NOD-like family of cytosolic pattern 
recognition receptors may provide another means by which effector response of 
astrocytes are generated against bacterial infection. Studies have demonstrated that 
members of this family, in particular NOD1 and NOD2, have the ability to interact with 
minimal motifs of peptidoglycan and, using the adapter molecule Rip2 kinase, result in 
the activation of the NFκB (Chamaillard et al. 2003b; Girardin et al. 2003a; Girardin et 
al. 2003b; Girardin and Philpott 2004). NFκB, as a pivotal transcription factor in the 
production of pro-inflammatory molecules, can contribute to the generation of effector 
functions in astrocytes. Additionally, astrocytes have been shown to respond functionally 
to commercial preparations of peptidoglycan with cytokine and chemokine production, 
which lends support to this possibility (Esen et al. 2004). 
 In the present study, we demonstrate that isolated murine astrocytes constitutively 
express robust levels of NOD2 and that such expression is significantly upregulated 
following exposure to two disparate and clinically relevant bacterial pathogens f the 
CNS, Borrelia burgdorferi and Neisseria meningitidis.  Similarly, NOD2 protein 
expression is elevated following exposure to specific bacterial ligands for TLRs.  
Importantly, astrocytes express Rip2 kinase, an essential downstream effector molecule 
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for NOD-mediated cell responses, and this expression is upregulated following microbial 
challenge.  Furthermore, we provide strong evidence for the functional nature of NOD2 
in astrocytes by demonstrating that a specific ligand for this cytosolic pattern recognition 
receptor can induce significant inflammatory cytokine production and can augment 
immune responses induced by TLR ligation.  The demonstration that astrocytes expres  
functional NOD2 proteins may represent a potentially important mechanism by which
this glial cell type can respond to bacterial infections of the CNS. 
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3.2 Results 
 
Induction of mRNA encoding NOD1 and NOD2 in murine astrocytes following 
bacterial exposure 
 
 To begin to determine whether astrocytes express these novel pattern recognition 
receptors, we have determined the level of expression of mRNA encoding NOD1 and 
NOD2 in isolated cultures of murine astrocytes either at rest or following challenge with 
clinically relevant gram-negative bacterial pathogens of the CNS.  Murine astrocytes 
were untreated or exposed to live N. meningitidis or bacterial lysates.  At 4 and 8 hours 
post-infection, RNA was isolated and real time PCR was performed for the pres nce of 
mRNA encoding NOD1 or NOD2.  As shown in Figure 5, there is very low constitutive 
expression of mRNA encoding NOD1 in resting cultures of astrocytes.  However, 
exposure of cells to either viable N. meningitidis or N. meningitidis antigens elicits 
modest but significant (p < 0.05) increases in the level of expression of mRNA encoding 
NOD1 (Figure 5).  The high level of variability in the data obtained at 30:1 N. 
meningitidis to each glial cell is most likely due to astrocyte cell death at this multiplicity 
of infection (data not shown).  In addition, we have also exposed primary astrocytes to B. 
burgdorferi antigens, a preparation that has previously been shown to be free of LPS 
(Anguita et al. 2002).  Challenge with this disparate gram-negative bacterium similarly 
elicited modest but significant elevations in NOD1 mRNA expression (Figure 5). 
 In contrast, resting astrocytes constitutively express mRNA encoding NOD2 at 
levels that are approximately three orders of magnitude greater than that seen for NOD1 
(Figure 6).  Furthermore, both N. meningitidis and B. burgdorferi antigens elicit 
significant increases in NOD2 mRNA expression in astrocytes (Figure 6A).  In addition, 
cells were exposed to LPS, flagellin, or an activating oligonucleotide to test wh ther 
 46
bacterial stimuli for TLR4, TLR5, or TLR9, respectively, can induce NOD protein 
expression in astrocytes.  As shown in Figure 6B, purified bacterial TLR ligands elicited 
significant increases in NOD2 mRNA levels and these increases occurred mo  rapidly 
than that seen for bacterial lysates. 
Induction of NOD1 and NOD2 protein expression in astrocytes following bacterial 
challenge 
 
 To determine whether the expression of mRNA encoding NOD1 or NOD2 in 
resting or bacterially challenged astrocytes results in the expression of these protein 
products, immunoblot analyses were performed.  Reagents for murine NOD proteins 
were not currently available and so polyclonal antibodies directed against human NOD1 
and NOD2 proteins were utilized due to their 89% and 78% homology to murine NOD1 
and NOD2, respectively (Girardin et al, 2003a; Strausberg et al, 2002).  Murine 
astrocytes were exposed to N. meningitidis or B. burgdorferi antigens at the indicated 
concentrations and whole cell protein isolates were obtained at 12 or 24 hours prior to 
immunoblot analysis for NOD1 or NOD2.  As shown in the representative experiment in 
Figure 7A, resting cultures of astrocytes showed very low levels of a protein that 
migrated close to the predicted size of the NOD1 protein (~130 kDa) and exposure to 
either bacterial species elicited only modest elevations in such expression as determined 
by densitometric analysis.  These findings are in agreement with the levels of mRNA 
encoding NOD1 shown in Figure 5.  In addition, cells were exposed to LPS, flagellin, or 
an activating oligonucleotide to test whether bacterial stimuli for TLRs can induce NOD 
protein expression in astrocytes.  However, these purified bacterial components elicited 
only modest elevations in NOD1 protein expression even at relatively high 
concentrations (Figure 7B). 
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 In contrast, murine astrocytes constitutively expressed robust levels of a protein 
that migrated close to the predicted size of NOD2 proteins (~115 kDa) (Figure 8A).  
Furthermore, NOD2 protein expression demonstrated a 2-fold induction following 
exposure to either N. meningitidis or B. burgdorferi antigens as determined by 
densitometric analysis (Figure 8A).  Again, these data are in agreement with the levels of 
mRNA encoding NOD2 observed in astrocytes constitutively and the upregulation 
observed following bacterial challenge (Figure 6).  In addition, levels of NOD2 protein 
expression were markedly increased following exposure to even low concentrations of 
TLR ligands (Figure 8B).  Interestingly, muramyl dipeptide (MDP), a specific ligand for 
NOD2, failed to elicit significant elevations in NOD2 protein expression at either 12 
hours (19.0 +/- 4.2 versus 18.4 +/- 4.9 arbitrary densitometric units for resting and MDP-
stimulated astrocytes, respectively) or 24 hours (29.0 +/- 5.0 versus 33.6 +/- 6.7 arbitrary 
densitometric units for resting and MDP-stimulated astrocytes, respectively) following 
challenge. 
Astrocytes express, Rip2 kinase, a pivotal downstream effector molecule for NOD 
signaling 
 
 To begin to determine whether astrocytes can express functional NOD pattern 
recognition receptors, we have investigated whether these cells express Rip2 kinase, a 
critical effector molecule in both NOD1 and NOD2-mediated cellular activation.  Cells 
were untreated or exposed to N. meningitidis or B. burgdorferi antigens for 4 or 12 hours.  
As shown in the representative experiment in Figure 9A, mRNA encoding Rip2 kinase is 
expressed in murine astrocytes, constitutively.  Importantly, exposure to either N. 
meningitidis or B. burgdorferi antigens elicit marked increases in levels of Rip2 kinase 
mRNA as rapidly as 4 hours post-treatment, with maximal increases of 4.6 and 4.8-fold, 
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respectively, over constitutive levels as determined by densitiometric analysis (Figure 
9A).  Furthermore, these increases were maintained up to 12 hours following bacterial 
exposure (Figure 9A).   On average, levels of mRNA encoding Rip2 kinase were 
significantly increased (p < 0.05) from 35 +/- 13 arbitrary densitometric units in 
unstimulated cells to 128 +/- 10 and 131 +/- 7 arbitrary densitometric units following 
exposure to B. burgdorferi and N. meningitidis, respectively. 
 To determine whether mRNA levels are representative of Rip2 kinase protein 
expression, immunoblot analyses were performed.  Murine astrocytes were untr ated or 
exposed to N. meningitidis or B. burgdorferi antigens for 24 hours.  As shown in the 
representative experiment in Figure 9B, unstimulated astrocytes expressed Rip2 kinase 
constitutively (60 kDa).  Importantly, the level of expression of this protein was 
increased by approximately 2- and 3-fold at 24 hours following challenge with N. 
meningitidis or B. burgdorferi antigens, respectively, as determined by densitometric 
analysis (Figure 9B).   On average, Rip2 kinase protein levels were significantly 
increased (p < 0.05) from 18 +/- 4 arbitrary densitometric units in unstimulated cells to 
70 +/- 10 and 42 +/- 7 arbitrary densitometric units following exposure to B. burgdorferi 
and N. meningitidis, respectively.  As such, the constitutive expression of this critical 
downstream effector molecule and its sensitivity to bacterial challenge, provides 
circumstantial evidence for the functionality of NOD proteins in astrocytes. 
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Astrocyte immune responses are augmented by a specific NOD2 agonist 
 To test whether astrocytes express functional NOD molecules we have 
investigated the ability of MDP, a well characterized and specific ligand for NOD2 
(Girardin et al. 2003b; Girardin et al. 2003c; Inohara et al. 2003), to induce cytokine 
production by these cells or augment immune responses induced by specific bacterial 
ligands for other pattern recognition receptors.  Astrocytes were untreated or exposed to 
MDP (1 and 5 µg/ml), in the presence or absence of LPS, flagellin, or an activating 
oligonucleotide at concentrations that elicit suboptimal cytokine responses by these cells.  
At 12 or 24 hours following treatment, culture supernatants were isolated and assayed for 
IL-1β, IL-6, and TNF-α content by specific capture ELISAs.  As shown in Figure 10, 
MDP elicited modest but significant elevations in both IL-6 and TNF-α production by 
astrocytes.  Importantly, MDP significantly increased (p < 0.05) IL-6 and TNF-α 
secretion by cells stimulated with LPS, flagellin or CpG (Figure 10).  Interestingly, 
combined exposure of cells to 5 µg/ml MDP and flagellin or LPS elicited significantly 
greater than additive (p < 0.05) elevations in TNF-α production at 24 hours post-
treatment (Figure 10B).  In contrast, MDP failed to augment IL-1β production by 
astrocytes either when used alone or in combination with TLR ligands (data not shown).  
Taken together, these data suggest that astrocytes express functional NOD2 receptors and 
that such molecules can act in a cooperative manner with TLRs to augment production of 
specific inflammatory cytokines. 
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3.3 Conclusions 
 
 Astrocytes are well known to play essential roles in the development, survival and 
functioning of CNS neurons.  However, it has become increasingly apparent that 
astrocytes may also be important contributors to inflammatory immune responses within 
the brain.  Stimulated astrocytes have been demonstrated to express an array of 
inflammatory cytokines and chemokines (Dong and Benveniste 2001) that could initiate
leukocyte migration through the blood brain barrier (Persidsky 1999).  Furthermore, it 
has been suggested that astrocytes express, or may be induced to express, antigen 
presenting class II MHC molecules and co-stimulatory molecules (Dong and Benveniste 
2001).  Importantly, astrocytes have been shown to mount such responses following 
exposure to microbial challenges (Krueger et al. 1995; Wesselingh and Thompson 2001). 
To date, the mechanisms by which these resident CNS cells perceive bacterial pa hogens 
remain unclear.  While our group (Bowman et al. 2003), as well as others (Bsibsi et al. 
2002; Esen et al. 2004; Carpentier et al. 2005), have recently described the presence of 
members of the Toll-like family of receptors on murine astrocytes, such expression does 
not prevent the possible involvement of other pattern recognition receptors in astrocyte 
activation.  Indeed, recent studies have suggested that disparate pattern recognition 
receptor types may act in a synergistic manner to promote inflammatory immune 
responses (Uehara et al. 2005). 
 NOD1 and NOD2 are members of a family of proteins whose members appear to 
serve as pattern recognition receptors (Ting and Davis 2005).  In the present study, we 
provide evidence for the expression of these novel pathogen-associated molecular pattern 
recognition receptors in murine astrocytes.  We demonstrate that these cells constitutively 
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express robust levels of NOD2 mRNA and show that expression is elevated following 
challenge with two clinically relevant bacterial pathogens of the CNS, N. meningitidis 
and B. burgdorferi.  In addition, NOD2 mRNA levels are rapidly upregulated following 
exposure to bacterial ligands for TLRs.  Such a finding is consistent with the previously 
documented ability of LPS to induce NOD2 mRNA expression in a monocytic cell line 
(Iwanaga et al. 2003).  Our current experiments have enabled us to confirm that isolated 
astrocytes express NOD2 protein constitutively and have elevated levels following 
bacterial challenge.  In contrast, resting astrocytes express little or no NOD1 and only 
modest expression was observed following bacterial challenge.   
 While both NOD1 and NOD2 detect bacterial peptidoglycans, differences exist 
between the specific motifs recognized by each in that NOD1 interacts with the naturally 
occurring peptidoglycan degradation product, GlcNAc-MurNAC-L-Ala-gamma-D-Glu-
meso-DAP, that is found in peptidoglycans from gram-negative bacteria while NOD2 
recognizes a minimal muramyl dipeptide motif, MurNAC-L-Ala-D-IsoGln (MDP), 
present in all peptidoglycans (Chamaillard et al. 2003b; Girardin et al. 2003a; Girardin et 
al. 2003b; Girardin et al. 2003c; Inohara et al. 2003; Girardin et al. 2005).  As such, it has 
been suggested that NOD1 represents a specific receptor for gram-negative bac eria while 
NOD2 is a more general sensor of bacteria (Girardin et al. 2003a; Girardin et al. 2003b).  
 Borrelia burgdorferi is the causative agent of Lyme neuroborreliosis and can 
elicit astrocyte immune responses (Ramesh et al. 2003) while Neisseria meningitidis is an 
important cause of bacterial meningitis (Kolb-Maurer et al. 2003) and induces elevated 
levels of inflammatory cytokine production in the cerebral spinal fluid of infected 
patients (Waage et al. 1989; Sharief et al. 1992; Kornelisse et al. 1997).  More 
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importantly, these organisms are gram-negative bacterial species posssing 
peptidoglycan motifs that can be recognized by both NOD homologues.  In the present 
study we show that exposure of astrocytes to either B. burgdorferi or N. meningitidis 
elevates the expression of both NOD1 and NOD2 in astrocytes (Figures 5-8), with NOD2 
being the predominant homologue as assessed at both the level of mRNA and protein 
expression.  However, it is possible that induction of NOD molecules occurs secondary to 
signaling via other pattern recognition receptors, rather than a direct conseque c  of 
bacterial ligands interacting with NOD receptors.  Support for this notion comes from the 
finding that ligands for TLRs can elicit elevations in NOD expression in astrocytes 
(Figures 6 and 8B) and a monocytic cell line (Iwanaga et al. 2003).  Furthermore, the 
NOD2 specific ligand, MDP, fails to augment NOD2 expression.  It is, therefore, likely
that B. burgdorferi and N. meningitidis indirectly induce NOD expression following 
engagement of other pattern recognition receptors. 
 Both NOD1 and NOD2 have been reported to associate with Rip2 kinase (Ogura 
et al. 2001b; Chin et al. 2002; Kobayashi et al. 2002; Yoo et al. 2002) and the present 
demonstration of the inducible expression of Rip2 kinase in astrocytes lends credence to 
the notion that NOD proteins are functional in this cell type.  Activation of this adaptor 
molecule results in the activation of NF-kB, a pivotal transcription factor in the 
production of cytokines such as IL-6 and TNF-α, and the induction of co-stimulatory 
molecules.  Hence, activation of astrocytes via NOD receptors could underlie, at least in 
part, the bacterially-induced immune molecule production previously reported in this cell 
type (Dong and Benveniste 2001).   
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 More direct evidence for the functional presence of NOD molecules in astrocytes 
comes from the demonstration that extracellular application of MDP, an apparent ligand 
for NOD2, can elicit modest but significant production of IL-6 and TNF-α (Figure 10).  
These findings are consistent with previous studies employing MDP that show that this 
molecule is a relatively poor stimulus in macrophages (Pauleau and Murray 2003).  
Importantly, we demonstrate that this NOD2 ligand can significantly augment cytokine 
production elicited by TLR agonists.  Furthermore, the presence of this NOD ligand can 
elicit inflammatory mediator production that is greater than the sum of each stimulus 
alone.   Such a finding is in agreement with previous studies in other cell types 
demonstrating that MDP can act in a synergistic manner with LPS to elicit inflammatory 
cytokines production. It must be noted that extracellular application of specific ligands 
for NOD proteins can initiate cellular responses (Pauleau and Murray, 2003; Wolfert et 
al, 2002; Yang et al, 2001) despite the predicted inability of these molecules to cross the 
plasma membrane.  To date, the precise mechanisms responsible for this uptake have yet 
to be determined, although it is possible that phagocytosis and/or 
pinocytosis/macropinocytosis underlie such uptake.  
 While it is presently unclear why MDP alone elicits only modest cytokine 
production by astrocytes, it is possible an initial stimulus is required to induce NOD2 
expression, thereby rendering astrocytes more sensitive to the presence of MDP.  
Alternatively, these findings may indicate that multiple signals, via dissimilar pattern 
recognition receptors, act in a synergistic manner to promote inflammatory as rocyte 
responses.  Regardless of which scenario is correct, the present study demonstrates that 
disparate bacterial pattern recognition receptors can act in a co-operative m nner to 
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initiate immune responses in astrocytes.  As such, the functional presence of NOD 
proteins in primary astrocytes may represent an important mechanism by which this cell 
type responds to bacterial CNS pathogens. 
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3.4 Figures 
 
Figure 5:  Expression of mRNA encoding NOD1 in isolated murine astrocytes.  Cell  (2 
X 106) were untreated (0) or exposed to whole viable N. meningitidis (Nm Live) (10 and 
30 bacteria to each astrocyte) or N. meningitidis antigens (Nm) (1 and 5 µg/ml) or B. 
burgdorferi antigens (Bb) (1 and 5 µg/ml).  At 4 and 8 hours post-treatment, RNA was 
isolated and real time PCR performed to determine the level of expression of mRNA
encoding NOD1.  Data are presented as the mean +/- SEM of four experiments 
normalized to the expression of G3PDH.  Asterisk indicates a statistically significant 
difference from untreated astrocytes. 
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Figure 6:  Expression of mRNA encoding NOD2 in isolated murine astrocytes.  Panel A: 
Cells (2 X 106) were untreated (0) or exposed to N. meningitidis antigens (Nm) (1 and 5 
µg/ml) or B. burgdorferi antigens (Bb) (1 and 5 µg/ml) for 4 and 8 hours.  Panel B: Cells 
were untreated (0) or exposed to lipopolysaccharide (LPS) (0.1 and 1 ng/ml), purified 
flagellin (Flg) (1 and 5 ng/ml), or an activating oligonucleotide (CpG) (0.1 and 1 µg/ml) 
for 4 hours.  At the indicated times RNA was isolated and real time PCR performed to 
determine the level of expression of mRNA encoding NOD2.  Data are presented as the 
mean +/- SEM of four experiments normalized to the expression of G3PDH.  Asterisk 
indicates a statistically significant difference from untreated astrocytes.
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Figure 7:  Astrocytes express only low levels of NOD1 protein following bacteri l 
challenge.  Panel A:  Isolated murine astrocytes (2 X 106) were untreated (0) or exposed 
to N. meningitidis antigens (Nm) (1, 2.5, and 5 µg/ml) or B. burgdorferi antigens (Bb) (1, 
2.5, and 5 µg/ml) for 12 hours.  Panel B: Cells were untreated (0) or treated with 
lipopolysaccharide (LPS) (10 and 100 ng/ml), purified flagellin (Flg) (10 and 100 ng/ml), 
or an activating oligonucleotide (CpG) (100 and 1000 ng/ml) for 24 hours.  After 
treatment, whole cell protein isolates were prepared and NOD1 protein expression wa  
determined by immunoblot and quantified by densitometric analysis.  Representative 
results are shown for one of three separate experiments with densitometric analyses 
normalized to β-actin expression.  For comparison purposes, immunoblots and 
densitometric analyses for NOD1 expression in the same number of LPS-activated 
murine peritoneal macrophages is shown (mφ). 
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Figure 8: Astrocytes constitutively express NOD2 protein and levels are elevated 
following challenge with bacterial pathogens or known ligands for Toll-like pattern 
recognition receptors.  Panel A:  Astrocytes (2 X 106) were untreated (0) or exposed to N. 
meningitidis antigens (Nm) (1, 2.5, and 5 µg/ml) or B. burgdorferi antigens (Bb) (1, 2.5, 
and 5 µg/ml) antigens for 24 hours.  Panel B:  Cells were untreated (0) or exposed to 
lipopolysaccharide (LPS) (10 and 100 ng/ml), purified flagellin (Flg) (10 and 100 ng/ml), 
or an activating oligonucleotide (CpG) (0.1 and 1 µg/ml) for 24 hours.  After treatment, 
whole cell protein isolates were prepared and NOD2 protein expression was determin d 
by immunoblot and quantified by densitometric analysis.  Representative results are 
shown of one of three separate experiments with densitometric analyses normalized to β-
actin expression. 
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Figure 9:  Astrocytes express Rip2 kinase, a critical downstream effector molecule of 
NOD signaling.  Panel A:  Cells (2 X 106) were untreated (0) or exposed to N. 
meningitidis antigens (Nm) (1 and 5 µg/ml) or B. burgdorferi antigens (Bb) (1 and 5 
µg/ml).  At 4 and 12 hours post-treatment, RNA was isolated and semi-quantitative RT-
PCR performed to determine expression of mRNA encoding Rip2 kinase.  PCR 
amplification of G3PDH was performed to ensure similar amounts of input RNA and 
similar efficiencies of reverse transcription.  These studies were perform d 3 times with 
similar results.  Panel B:  Cells were untreated (0) or exposed to N. meningitidis antigens 
(Nm) (1, 2.5, and 5 µg/ml) or B. burgdorferi antigens (Bb) (1, 2.5, and 5 µg/ml) antigens 
for 24 hours.  After treatment, whole cell protein isolates were prepared and Rip2 kinase
protein expression was determined by immunoblot and quantified by densitometric 
analysis.  Representative results from one of three separate experiments are shown with 
densitometric analyses normalized to β-actin expression. 
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Figure 10: A NOD2 specific ligand, MDP, augments inflammatory cytokine producti n 
by murine astrocytes.  Cells (2 X 106) were untreated (0) or exposed to muramyl 
dipeptide (MDP) (1 and 5 µg/ml) in the presence or absence of lipopolysaccharide (LPS) 
(1 ng/ml), purified flagellin (Flg) (1 ng/ml), or an activating oligonucleotide (CpG) (100 
ng/ml).  At 24 hours post treatment, culture supernatants were assayed for the presence of 
IL-6 (Panel A) or TNF-α (Panel B) by specific capture ELISAs.  Data are presented as 
the mean of triplicate determinations +/- SEM.  Asterisks indicate statistic lly significant 
difference between cytokine levels detected in the absence and presence of MDP within 
each bacterial stimuli group. 
 
 
 
 
 
 
 
 
CHAPTER 4: EXPRESSION OF NOD2 IN PRIMARY MURINE 
MICROGLIA 
 
 
4.1 Rationale 
 
 Microglia are resident immune cells of the CNS and, like macrophages and 
dendritic cells, are of myeloid lineage.  This important glial cell type responds to 
traumatic injury or the presence of infectious organisms by migrating to thesite of injury 
and undergoing rapid proliferation.  These cells then become activated at the site of 
challenge, assuming many of the immune effector functions typically associated with 
macrophages.  Microglia are capable of serving as facultative phagocytes and express 
antigen presenting MHC class II molecules. These effector functions, c mbined with the 
expression of co-stimulatory molecules, allow microglia to act as professi nal antigen 
presenting cells (Hickey and Kimura 1988).  Additionally, microglia can be induced to 
produce key pro-inflammatory molecules such as TNF-α and IL-6 (Kiefer et al. 1993; 
Streit et al. 1999). As such, these cells are ideally suited to detect and respond to 
pathogens that infiltrate the CNS.  Our group has recently demonstrated that microglia 
can respond to Borrelia burgdorferi and Neisseria meningitidis, two clinically relevant 
Gram-negative bacterial pathogens of the CNS (Rasley et al. 2002a; Rasley et al. 2006).  
Other groups have demonstrated that the Gram-positive organism, S. aureus, similarly 
elicits pro-inflammatory responses by purified cultures of microglia (K elian et al. 2002; 
Kielian et al. 2004).   
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 However, the mechanisms by which these cells identify bacterial pathogens are 
poorly understood.  Recent studies have demonstrated that microglia express members of 
the Toll-like family of receptors (TLR) that recognize conserved bacteril motifs.  
Microglia express TLR2, TLR4, TLR5, and TLR9, which are known receptors for 
lipoproteins/peptidoglycan, lipopolysaccharide (LPS), bacterial flagellin, and 
unmethylated CpG motifs, respectively (Bsibsi et al. 2002; Rasley et al. 2002a; Olson 
and Miller 2004; Esen and Kielian 2005; Kielian et al. 2005a).  However, the expression 
of these molecules does not eliminate the possible involvement of other pattern 
recognition receptors in the perception of bacterial pathogens by these cells.  
 A recent study has suggested that peptidoglycan perception is mediated by 
members of the novel nucleotide-binding oligomerization domain (NOD) family of 
proteins rather than by TLR2 (Travassos et al. 2004).  NOD proteins have been identified 
in both immune and non-immune cell types and at least two members of this family of 
proteins appear to serve as cytosolic pattern recognition receptors (Ting and Davis 2005; 
Strober et al. 2006).  NOD1 (also designated CARD4) appears to interact with motifs 
found in peptidoglycans from Gram-negative bacteria (Chamaillard et al. 2003b; Girardin 
et al. 2003a; Girardin et al. 2003e).  In contrast, NOD2 (also designated CARD15) has 
been suggested to be a more general sensor of bacterial peptidoglycans as it recognizes a 
minimal motif present in all peptidoglycans (Girardin et al. 2003b; Girardin et al. 2003c; 
Girardin et al. 2003e; Inohara and Nunez 2003).  Both NOD1 and NOD2 have been 
reported to associate with Rip2 kinase (also designated RICK and CARDIAK) (Ogura et 
al. 2001b; Chin et al. 2002; Kobayashi et al. 2002; Yoo et al. 2002), the activation of 
which ultimately results in the activation of NF-kB, a pivotal transcription factor in the 
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production of pro-inflammatory mediators.  As such, NOD molecules could play an 
important role in the detection of bacterial CNS pathogens and the initiation of 
inflammation within the brain.  To date, the expression of these novel bacterial pattern 
recognition receptors has not been investigated in microglia. 
 In the present study, we demonstrate that isolated murine microglia constitutively 
express robust levels of NOD2 and show that such expression is upregulated following 
exposure to two disparate bacterial pathogens of the CNS, Borrelia burgdorferi, and 
Neisseria meningitidis.  Similarly, NOD2 protein expression is elevated following 
exposure to specific bacterial ligands for TLRs.  The notion that NOD2 is functional in 
these cells is supported by the observation that muramyl dipeptide (MDP), a specific 
ligand for NOD2, can also elevate levels of this receptor and by the demonstrati  hat 
microglia express Rip2 kinase, an essential downstream effector molecule for NOD-
mediated cell responses.  Finally, compelling evidence for the functional nature of NOD2 
expression in microglia is provided by the demonstration that MDP can augment 
inflammatory cytokine production induced by TLR ligation in a synergistic/non-additive 
manner.  Taken as a whole, the demonstration that microglia express functional NOD2 
proteins may represent a potentially important mechanism by which this glial cel  type 
can respond to bacterial infections of the CNS. 
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4.2 Results 
 
Microglia express mRNA encoding NOD molecules 
 To begin to determine whether microglia express these novel pattern recognition 
receptors we have assessed the level of mRNA expression encoding NOD1 and NOD2 in 
isolated cultures of murine microglia either at rest or following challenge with clinically 
relevant Gram-negative bacterial pathogens of the CNS.  Murine microglia were 
untreated or exposed to live N. meningitidis.  At 4 hours post infection, RNA was isolated 
and real time PCR was performed for the presence of mRNA encoding NOD1 or NOD2.  
As shown in Figure 11A, microglia constitutively express very low levels of mRNA 
encoding NOD1.  Exposure of microglia to viable N. meningitidis fails to elicit 
significant increases in such expression (Figure 11A).  In contrast, resting microglia 
constitutively express mRNA encoding NOD2 at levels that are approximately two orders 
of magnitude greater than those seen for NOD1 (Figure 11B).  Furthermore, exposur  of 
microglia to viable N. meningitidis significantly increases NOD2 mRNA expression 
(Figure 11B).  Similarly, mixed N. meningitidis antigen isolates elicit marked elevations 
in expression of mRNA encoding NOD2, but not NOD1 (Figures 11B and 11A, 
respectively).  Finally, we have investigated the effects of a disparate bac rial pathogen, 
B. burgdorferi, on NOD mRNA expression.  As shown in Figure 11, B. burgdorferi 
antigens also significantly elevate NOD2 mRNA expression. 
 The ability of whole cell bacterial lysates to induce NOD2 mRNA expression 
indicates that a dynamic interaction between viable bacteria and murine cells is not 
required for this effect.  Rather, it suggests that bacterial motifs are a full and sufficient 
stimulus to induce NOD2 mRNA expression in microglia.  To further investigate this 
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possibility, we have assessed the ability of purified microbial components to induce 
NOD2 mRNA expression.  Microglia were exposed to the minimal peptidoglycan motif,
muramyl dipeptide (MDP), a known ligand for NOD2 (Girardin et al. 2003b; Girardin et 
al. 2003e; Inohara et al. 2003).  As shown in Figure 12A, MDP elicits modest but 
significant increases in levels of mRNA encoding NOD2.  This effect was specific for 
NOD2, as MDP failed to elicit significant increases in the expression of mRNA encoding 
NOD1 (Figure 12A).  Furthermore, we have investigated the effect of known bacterial 
ligands for members of the Toll-like family of pattern recognition receptors on NOD2 
mRNA expression.  As shown in Figure 12B, bacterial LPS and flagellin, ligads for 
TLR4 and TLR5, respectively, elicit marked and rapid increases in NOD2 mRNA levels.  
In contrast, specific ligands for TLR2 and TLR9 (Pam(3)Cys and an activating 
oligonucleotide, respectively) fail to significantly alter NOD2 mRNA expression (Figure 
12B). 
Microglia express elevated levels of NOD proteins following bacterial challenge  
 To determine whether expression of mRNA encoding NOD molecules in 
microglia translates into expression of these proteins, immunoblot analyses were 
performed.  Reagents for murine NOD proteins were not currently available, so w  
employed polyclonal antibodies directed against human NOD molecules to detect th  
presence of murine NOD1 and NOD2 due to their 89% and 78% homology to human 
NOD1 and NOD2, respectively (Strausberg et al. 2002; Girardin et al. 2003a).  As shown
in Figure 13, murine microglia constitutively express low levels of NOD2 protein.  
Importantly, exposure of these cells to N. meningitidis or B. burgdorferi antigens results 
in marked increases in NOD2 protein expression of approximately 8- and 5-fold, 
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respectively.  However, antigens derived from the Gram-positive bacterial pathogen, S. 
aureus, previously shown to elicit microglial responses in part via TLR2 (Kielian et al. 
2005b), fail to elicit significant increases in such expression (Figure 13A).  This finding 
is consistent with the ability of LPS and flagellin to markedly elevate NOD2 protein 
expression while the TLR2 ligand, Pam(3)Cys, does not (Figure 13B). 
 In contrast, microglia constitutively express little or no NOD1 protein (Figure 14).  
Exposure of microglia to bacteria or bacterial components elicited only modest elevations 
in NOD1 expression (Figure 14).  It is noteworthy that such expression was 
inconsistently observed and was only detectable on immunoblots loaded with three times 
the input protein used for NOD2 assays. 
Microglia express Rip2 kinase, a pivotal downstream effector molecule for NOD 
signaling 
 
 To begin to determine if NOD proteins are functional in microglia, we have 
investigated whether these cells express Rip2 kinase, a critical downstream eff ctor 
molecule in both NOD1 and NOD2-mediated cellular activation.  As shown in Figure 
15A, microglia constitutively express low levels of mRNA encoding Rip2 kinase.  
However, such expression is rapidly and markedly upregulated following exposure to 
either N. meningitidis or B. burgdorferi antigens (Figure 15A).  Interestingly, bacterial 
ligands for TLR2, TLR4, and TLR5 similarly elevate Rip2 kinase mRNA levels, while 
ligands for TLR9 and NOD2 do not. This indicates a measure of specificity in the 
regulation of this important signaling component. 
 To confirm that microglia express Rip2 kinase, whole cell protein isolates were 
probed for the presence of this molecule by immunoblot analysis.  As shown in Figures 
15B and C, resting microglia express robust levels of this protein.  While microglia 
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exposed to N. meningitidis or B. burgdorferi antigens tended to have higher Rip2 kinase 
protein levels, these differences were not statistically significant (Figure 15B).  However, 
purified bacterial components elicited an approximately 2-fold induction in Rip2 kinase 
protein expression (Figure 15C).  Curiously, the ligand for TLR9 significantly elevated 
levels of Rip2 kinase protein despite failing to elicit demonstrable changes in mRNA 
levels.  Taken together, the constitutive expression of this critical downstream effector 
molecule and its sensitivity to bacterial challenge provide circumstantial evidence for the 
functionality of NOD proteins in microglia. 
MDP augments TLR ligand-induced inflammatory cytokine production by 
microglia 
 
 To more directly assess the functionality of NOD2 protein expression in 
microglia, we have investigated the effects of MDP on production of key inflammatory 
mediators by these cells.  As shown in Figure 16, MDP treatment alone elicited modest 
but significant increases in IL-1β at the highest dose used (Figure 16B).  In contrast, 
MDP failed to induce significant secretion of IL-6 (Figure 16A) or TNF-α (Figure 16C).  
However, this NOD2 ligand markedly augmented the expression of all of these important 
inflammatory cytokines when used in combination with specific bacterial ligands for 
TLRs.  MDP significantly increased the production of IL-1β, IL-6 and TNF-α following 
exposure to LPS or flagellin.  Interestingly, increases were greater th n additive for 
flagellin-induced IL-1β, IL-6 and TNF-α, and LPS-induced IL-6 and TNF-α.  The ability 
of this NOD2 ligand to augment TLR-mediated immune responses appears to show 
specificity as MDP increased Pam(3)Cys-induced IL-6 and TNF-α but not IL-1β.  
Furthermore, MDP fails to significantly elevate cytokine production by microglia 
exposed to activating oligonucleotides (CpG).  Taken together, these data demonstrate 
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that microglia express functional NOD2 receptors and suggest that these molecules can 
act in a cooperative manner with specific TLRs to augment production of pivotal 
inflammatory cytokines. 
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4.3 Conclusions 
 
 Traumatic injury and infectious agents can elicit marked inflammatory responses 
within the CNS.  While such responses may represent protective immunity against 
certain pathogens, inflammation elicited by infectious agents often results in progressive 
damage to the CNS.  An accumulating body of evidence suggests that resident glial cells 
play a major role in host responses to microbial infection.  Microglia are of the same 
cellular lineage as macrophages and are, therefore, likely to play a key role in h st
defense against invading pathogens (Benveniste 1997b; Benveniste 1997a; Gonzalez-
Scarano and Baltuch 1999; Stoll and Jander 1999).  Our group has previously 
demonstrated that microglia can respond to B. burgdorferi and N. meningitidis through 
the production of key inflammatory mediators, namely IL-6 and TNF-α (Rasley et al. 
2002a; Rasley et al. 2006).  B. burgdorferi is the causative agent of Lyme 
neuroborreliosis while N. meningitidis is an important cause of bacterial meningitis 
making them clinically relevant pathogens of the CNS (Kolb-Maurer et al. 2003). To 
date, the mechanisms by which these resident CNS cells perceive bacterial challenges 
remain unclear.  Our groups, as well as others, have recently described the presence of 
members of the Toll-like family of receptors on murine microglia.  However, such
expression does not preclude the involvement of other pattern recognition receptors in 
microglial activation (Bsibsi et al. 2002; Rasley et al. 2002a; Olson and Miller 2004; 
Esen and Kielian 2005).  Indeed, there is a growing perception that disparate pattern 
recognition receptor types act in a synergistic manner to promote maximal inflammatory 
immune responses (Uehara et al. 2005). 
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 NOD1 and NOD2 are members of a family of proteins whose members are 
thought to serve as pattern recognition receptors for bacterial peptidoglycans (Ting and 
Davis 2005; Strober et al. 2006).  In the present study, we provide evidence for the 
expression of such novel pathogen-associated molecular pattern receptors in primary
microglia.  We demonstrate that these cells constitutively express robust level  of mRNA 
encoding NOD2 and detectable amounts of this cytosolic protein.  NOD2 mRNA 
expression is markedly elevated following exposure to the Gram-negative pathogen of 
the CNS, N. meningitidis.  Interestingly, this effect appears to be independent of bacterial 
viability, as whole cell lysates are at least as effective as live bacteria in augmenting 
NOD2 expression.  Mixed antigen preparations from a disparate Gram-negative bac erial 
CNS pathogen, B. burgdorferi, similarly induced NOD2 levels in microglia.  However, 
this effect shows pathogen specificity as lysates of Gram-positive S. aureus fail to induce 
increases in NOD2 protein levels.  These data suggest that certain bacterial components 
are a full and sufficient stimulus for NOD2 expression.  Surprisingly, a specific ligand for 
NOD2 induced relatively modest increases in NOD2 expression.  In contrast, agonists f r 
TLR4 and TLR5 proved to be potent stimuli for NOD2 levels suggesting that cross-
regulation may occur between disparate pattern recognition receptors.  Such a finding is 
consistent with the previously documented ability of LPS to induce NOD2 mRNA 
expression in a monocytic cell line (Iwanaga et al. 2003).  It is noteworthy that a specific 
ligand for TLR2 does not augment NOD2 expression in microglia.  This observation is 
consistent with the inability of S. aureus antigens to induce NOD2 protein levels (Figure 
13) because microglial responses to this pathogen appear to be mediated, in part, by 
TLR2 (Kielian et al. 2005a). 
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 In contrast to NOD2, our data indicated that resting microglia express little or no 
NOD1 and only modest expression was observed following bacterial challenge.  While 
this finding might be considered surprising because NOD1 has been reported to interact
with the naturally occurring peptidoglycan degradation product GlcNAc-MurNAC-L-
Ala-gamma-D-Glu-meso-DAP that is found in peptidoglycans from Gram-negativ  
bacteria (Chamaillard et al. 2003b; Girardin et al. 2003a; Girardin et al. 2003e), our data 
is consistent with previous studies showing that other myeloid cell types including 
macrophages preferentially express NOD2 (Strober et al. 2006).  In contrast, intestinal 
epithelial cells have been demonstrated to express NOD1 almost exclusively (Strober et 
al. 2006), as evidenced by the robust NOD1 protein levels in protein isolates from small 
intestine tissue (Figure 14). 
 Both NOD1 and NOD2 have been reported to associate with Rip2 kinase (Ogura 
et al. 2001b; Chin et al. 2002; Kobayashi et al. 2002; Yoo et al. 2002) and the present 
demonstration of inducible Rip2 kinase expression in microglia lends credence to the 
notion that NOD proteins are functional in this cell type.  Activation of this adaptor 
molecule results in the activation of NF-kB, a pivotal transcription factor in the 
production of cytokines including IL-1β, IL-6, and TNF-α, and the induction of co-
stimulatory molecules.  Hence, activation of microglia via NOD receptors could underlie, 
at least in part, the bacterially-induced immune molecule production previously reported 
in this cell type.   
 More direct evidence for the functional presence of NOD molecules in microglia 
comes from the observation that extracellular application of MDP, an apparent ligand for 
NOD2, can elicit modest but significant production of IL-1β (Figure 16).  These findings 
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are consistent with previous studies employing MDP showing that this molecule is a 
relatively poor stimulus in macrophages (Pauleau and Murray 2003).  However, we 
demonstrate that this NOD2 ligand can significantly augment cytokine producti n 
elicited by TLR agonists.  Importantly, co-treatment of microglia with MDP and TLR 
ligands elicits inflammatory mediator production that is greater than the sum of each 
stimulus alone.  This finding is in agreement with studies in other cell types showing that 
MDP can act in synergy with LPS to elicit inflammatory cytokine production (Ribi et al. 
1979; Yang et al. 2001; Wolfert et al. 2002; Li et al. 2004).  It must be noted that 
extracellular application of specific ligands for NOD proteins can initiate cellular 
responses despite the predicted inability of these molecules to cross the plasma 
membrane (Yang et al. 2001; Wolfert et al. 2002; Pauleau and Murray 2003).  To date, 
the precise mechanisms responsible for this uptake have yet to be determined, although it 
is possible that phagocytosis and/or pinocytosis/macropinocytosis underlie such uptake.
  While it is presently unclear why MDP alone elicits only modest cytokine 
production by microglia, it is possible an initial stimulus is required to induce NOD2 
expression, thereby rendering microglia more sensitive to the presence of MDP.  
Alternatively, these findings may indicate that multiple signals, via dissimilar pattern 
recognition receptors, act in a synergistic manner to promote inflammatory microglial 
responses.  Regardless of which scenario is correct, the present study demonstrates that 
disparate bacterial pattern recognition receptors can act in a co-operative m nner to 
initiate immune responses in this resident CNS cell type.  As such, the functional 
presence of NOD proteins in primary microglia may represent an important mechanism 
by which this cell type responds to bacterial CNS pathogens.
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4.4 Figures 
 
Figure 11:  Primary murine microglia constitutively express mRNA encoding members 
of the NOD family of cytosolic pattern recognition receptors and such expression i  
elevated following bacterial challenge.  Cells (2 X 106) were untreated (0) or exposed to 
live N. meningitidis (Nm) (3:1, 10:1, and 30:1 ratios of bacteria to cells), N. meningitidis 
antigens (Nm Ag) (1, 2.5, and 5 µg/ml), or B. burgdorferi antigens (Bb Ag) (1, 2.5, 5 
µg/ml).  At 4 hours following treatment, mRNA was isolated and real time PCR 
performed to determine the level of expression of mRNA encoding NOD1 (Panel A) or 
NOD2 (Panel B).  Data are presented as the mean +/- SEM of five experiments 
normalized to the expression of G3PDH.  Asterisk indicates a statistically significant 
difference from untreated microglia. 
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Figure 12:  Expression of mRNA encoding NOD2 is elevated following exposure to th
NOD2 specific ligand, MDP, or known ligands for Toll-like pattern recognition 
receptors. Panel A: Cells (2 X 106) were untreated (0) or exposed to MDP (1 and 5 
µg/ml) for 4 and 8 hours prior to mRNA isolation and real time PCR for NOD1 or NOD2 
expression.  Panel B: Cells (2 X 106) were untreated (0) or exposed to Pam(3)Cys (PAM) 
(1 and 5 ng/ml), lipopolysaccharide (LPS) (1 and 10 ng/ml), purified flagellin (FLG) (1 
and 5 ng/ml), or an activating oligonucleotide (CpG) (0.1 and 1 µg/ml) for 4 and 8 hours 
prior to mRNA isolation and real time PCR for NOD2 expression. Data are presented as 
the mean +/- SEM of three experiments normalized to the expression of G3PDH.  
Asterisk indicates a statistically significant difference from untreated microglia. 
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Figure 13:  Microglia constitutively express low levels of NOD2 protein and such 
expression is elevated following bacterial challenge or exposure to Toll-like receptor 
ligands.  Panel A: Cells (2 X 106) were untreated (0) or exposed to N. meningitidis 
antigens (Nm Ag) (1 and 5 µg/ml), B. burgdorferi antigens (Bb Ag) (1 and 5 µg/ml), or S. 
aureus antigens (1 and 5 µg/ml).  Panel B: Cells (2 X 106) were untreated (0) or exposed 
to Pam(3)Cys (PAM) (10 ng/ml), lipopolysaccharide (LPS) (100 ng/ml), purified 
flagellin (FLG) (10 ng/ml), or an activating oligonucleotide (CpG) (1 µg/ml).  At 24 
hours post-treatment, whole cell protein isolates were prepared and NOD2 protein 
expression was determined by immunoblot.  Bands were quantified by densitometric 
analyses normalized to β-actin expression.  Bar graph in panel A depicts average values 
+/- SD for three experiments.  Bar graph in Panel B depicts normalized densitometr c 
values for immunoblot shown which is representative of four separate experiments.  For 
comparison purposes NOD2 protein expression in a similar number of LPS and IFN-γ 
stimulated macrophages is shown (mφ). 
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Figure  14:  Microglia express little or no NOD1 protein constitutively, and only modest 
levels following bacterial antigen challenge. Cells (2 X 106) were untreated (0) or 
exposed to N. meningitidis antigens (Nm Ag) (5 µg/ml), B. burgdorferi antigens (Bb Ag) 
(5 µg/ml), Pam(3)Cys (PAM) (10 ng/ml), lipopolysaccharide (LPS) (100 ng/ml), purified 
flagellin (FLG) (10 ng/ml), or an activating oligonucleotide (CpG) (1 µg/ml).  At 24 
hours post-treatment, whole cell protein isolates were prepared and NOD1 protein
expression was determined by immunoblot.  Bar graph depicts results of densitometric 
analyses normalized to β-actin expression for immunoblot shown, and this experiment 
was performed twice with similar results.  For comparison purposes NOD1 expression in 
protein samples from small intestine tissue is also shown (INT). 
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Figure 15: Microglia constitutively express Rip2 kinase, a critical downstream effector 
molecule of NOD signaling, and such expression is elevated following bacterial 
challenge.  Panel A: Cells (2 X 106) were untreated (0) or exposed to N. meningitidis 
antigens (Nm Ag) (1 and 5 µg/ml), B. burgdorferi antigens (Bb Ag) (1 and 5 µg/ml), 
muramyl dipeptide (MDP) (1 and 5 µg/ml), Pam(3)Cys (PAM) (1 and 10 ng/ml), 
lipopolysaccharide (LPS) (10 and 100 ng/ml), purified flagellin (FLG) (1 and 10 ng/ml), 
or an activating oligonucleotide (CpG) (0.1 and 1 µg/ml).  At 4 hours post treatment, 
RNA was isolated and real time RT-PCR performed to determine expression of mRNA
encoding Rip2 kinase.  Data are presented as the mean +/- SEM of three experiments 
normalized to the expression of G3PDH.  Asterisk indicates a statistically significant 
difference from untreated microglia.  Panels B and C: Cells (2 X 106) were untreated (0) 
or exposed to N. meningitidis antigens (Nm Ag) (1 and 5 µg/ml), B. burgdorferi antigens 
(Bb Ag) (1 and 5 µg/ml) (Panel B), or Pam(3)Cys (PAM) (10 ng/ml), lipopolysaccharide 
(LPS) (100 ng/ml), purified flagellin (FLG) (10 ng/ml), or an activating oligonucleotide 
(CpG) (1 µg/ml) (Panel C).  At 24 hours post-treatment, whole cell protein isolates wer 
prepared and Rip2 kinase protein expression was determined by immunoblot.  Bands 
were quantified by densitometric analyses normalized to β-actin expression and bar 
graphs depict average values +/- SD for three experiments.  For comparison purposes 
Rip2 kinase protein expression in a similar number of LPS and IFN-γ stimulated 
macrophages is shown (mφ). 
 78
 
 
Figure 16: MDP, a NOD2 specific ligand, augments inflammatory cytokine producti n 
by murine microglia.  Cells (2 X 106) were untreated (0) or exposed to muramyl dipeptide 
(MDP) (1 and 5 µg/ml) in the presence or absence of Pam(3)Cys (PAM) (10 ng/ml), 
lipopolysaccharide (LPS) (10 ng/ml), purified flagellin (FLG) (1 ng/ml), or an activating 
oligonucleotide (CpG) (1 µg/ml).  At 12 and/or 24 hours post treatment, culture 
supernatants were assayed for the presence of IL-6 (Panel A), IL-1β (Panel B), or TNF -α 
(Panel C) by specific capture ELISAs.  Data are presented as the mean of duplicate 
measurements of samples from three separate experiments +/- SEM.  Asterisks indicate 
statistically significant difference between cytokine levels detect d in the absence and 
presence of MDP within each stimuli group. 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5: FUNCTIONAL ROLE OF NOD2 IN MICROGLIA 
AND ASTROCYTES 
 
 
5.1 Rationale 
 
 Microglia and astrocytes are major glial cell types within the CNS. Studies 
conducted by our group, as well as others, have highlighted these cell types as important 
contributors to the generation of inflammation during infection of the brain. It has been 
demonstrated that these resident glial cells, upon exposure to pathogens of the CNS, are 
able to assume effector functions such as cytokine production and the expression of MHC 
class II molecules. The production of inflammatory mediators may serve to recruit 
leukocytes to the site of challenge and, in combination with antigen presentation in the 
context of MHC class II molecules, activate those cells upon their arrival (Hickey and 
Kimura 1988; Hatten et al. 1991; Kiefer et al. 1993; Benveniste 1997a; Soos et al. 1998; 
Streit et al. 1999; Owens et al. 2005). Our group has already demonstrated that microglia 
and astrocytes have the ability to detect and respond to clinically relevant bacterial 
pathogens of the CNS, including Borrelia burgdorferi and Neisseria meningitidis (Rasley 
et al. 2002a; Bowman et al. 2003; Rasley et al. 2004b; Rasley et al. 2006). However, the 
mechanisms by which these important resident glial cells perceive bacterial pathogens are 
only recently being described.  
 Studies have demonstrated that microglia and astrocytes utilize pattern 
recognition receptors as a means by which to identify and respond to microbial 
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pathogens. Studies conducted by our group as well have others have reported the 
expression of Toll-likereceptor family members known to be important in the perception 
of extracellular bacterial pathogens (Laflamme and Rivest 2001; Bsibsi et al. 2002; 
Rasley et al. 2002a; Bowman et al. 2003; Esen et al. 2004; Olson and Miller 2004; 
Carpentier et al. 2005; Esen and Kielian 2005; Kielian et al. 2005a). However, Borrelia 
burgdorferi and Neisseria meningitidis are known to be internalized by eukaryotic cells 
and the mechanisms by which intracellular bacteria are identified in microglia and 
astrocytes have not yet been established (Dehio et al. 2000; Livengood and Gilmore 
2006). 
 We have already demonstrated that microglia and astrocytes constitutively 
express NOD2, a member of the novel neucleotide-binding domain leucine-rich repeat 
region containing family of proteins (NLR) (See Chapter 3 and 4). This molecule 
functions as an intracellular receptor for a minimal motif present in all types of bacterial 
peptidoglycans. Those studies have provided circumstantial evidence that this pattern 
recognition receptor is functional within microglia and astrocytes. Indeed, functionality 
can be inferred from the ability of TLR ligands and Borrelia burgdorferi and Neisseria 
meningitidis antigens to significantly upregulate expression of NOD2 within these cell 
types. Further evidence exists in the inducibility of Rip2 kinase, a critical downstream 
effector molecule of this pathway. Finally, we have also demonstrated that mur myl 
dipeptide, a known ligand for NOD2, can significantly augment TLR-mediated 
inflammatory cytokine production in both microglia and astrocytes.  
 In the current study, we have confirmed the functional nature of NOD2 pathway 
expression in microglia and astrocytes. Additionally, we have taken steps to investigate 
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the relative contribution of this pathway in the generation of inflammatory responses to 
clinically relevant bacterial CNS pathogens. We demonstrate increased as ociation of 
NOD2 with its downstream adaptor molecule Rip2 kinase in primary cultures of murine 
microglia and astrocytes following exposure to bacterial antigens. Furthermore, we 
demonstrate that NOD2 underlies the ability of muramyl dipeptide to augment glial 
immune responses. Finally, we also show that NOD2 represents an important component 
in the generation of inflammatory immune responses of resident glia to Borrelia 
burgdorferi and Neisseria meningitidis. 
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5.2 Results 
 
Increased association of NOD2 with Rip2 kinase in murine microglia and astrocytes 
following bacterial challenge 
 
To establish the functional relevance of NOD2 expression in resident CNS cells, 
we investigated the ability of NOD2 to associate with its downstream effector molecule, 
Rip2 kinase, in isolated cultures of primary murine microglia and astrocytes using co-
immunoprecipitation techniques. As shown in Figure 17, protein isolates from resting 
cultures of microglia and astrocytes exhibit constitutive association between NOD2 with 
Rip2 kinase. Importantly, the level of association between NOD2 and Rip2 kinase is 
elevated in both microglia and astrocytes following exposure to lysates prepared from N. 
meningitidis or B. burgdorferi, two clinically relevant bacterial pathogens of the CNS that 
have been demonstrated to be internalized by glial cells (Livengood and Gilmore, 2006) 
As such, the increased association of these molecules provides circumstantial evidence 
supporting a functional role for NOD2 in the immune responses of resident CNS cells 
types following bacterial challenge. 
MDP augmentation of inflammatory cytokine production by stimulated microglia 
and astrocytes is mediated by NOD2  
 
In this study we have confirmed our previous findings in microglia and astrocytes 
derived from BALB/c mice using those derived from C57BL/6 mice. As shown in Figure 
18A, C, MDP alone fails to elicit significant production of IL-6 or TNF-α. However, this 
NOD2 ligand significantly augments the production of both of these inflammatory 
cytokines by microglia following exposure to the TLR4 and TLR5 specific ligands, LPS 
and flagellin, respectively. Similarly, MDP augments LPS and flagellin induced IL-6 and 
TNF-α production by isolated astrocytes (Fig. 19A, C). Importantly, we have confirmed 
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that the effects of MDP are mediated by NOD2 by performing parallel experiments using 
microglia and astrocytes derived from animals genetically deficient in the expression of 
NOD2 (NOD2-/-). As shown in Figure, 18B, D, MDP fails to augment inflammatory 
cytokine production by NOD2-/- derived microglia challenged with LPS or flagellin. 
Similarly, MDP does not elevate TLR-induced IL-6 or TNF-α production by astrocytes 
derived from NOD2-/- mice (Fig. 19B, D). These data confirm that MDP acts via NOD2 
and can augment TLR-induced inflammatory cytokine production by both microglia and 
astrocytes. 
NOD2 is required for maximal in vitro responses of microglia and astrocytes to N. 
meningitidis and B. burgdorferi 
 
To begin to determine the relative importance of the NOD2 receptor in 
inflammatory glial responses to bacterial pathogens, we have compared the responses of 
N. meningitidis and B. burgdorferi challenged cells derived from wild-type animals 
(NOD2+/+) with those of cells derived from NOD2-/- animals. As shown in Figure 20, 
microglia produce IL-6 and TNF-α in response to exposure to N. meningitidis or B. 
burgdorferi antigens. Importantly, cells derived from NOD2-/- mice exhibited 
significantly lower responses than their NOD2+/+ derived counterparts (see Figur  20). 
Similarly, NOD2-/- derived astrocytes produce significantly lower amounts of IL-6 and 
TNF-α than wild-type derived cells following bacterial challenge (see Figure 21). Taken 
together, these data indicate that NOD2 is an important contributor to the in vitro 
inflammatory immune responses of resident CNS cell types to these two clinically 
relevant bacterial pathogens. 
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CNS Inflammation Following In Vivo Bacterial Administration are reduced in the 
Absence of NOD2 
 
To establish the in vivo role of NOD2 in bacterially induced inflammatory glial
responses, we have investigated the generation of inflammation associated with in vivo 
administration of N. meningitidis in the presence or absence of NOD2. As shown in 
Figure 22, the infection of the CNS with N. meningitidis results in the production of 
statistically significant levels of the pro-inflammatory cytokine TNF-α. This significant 
increase was not apparent in NOD2-/- mice.  We extended our in vivo studies to include
the disparate CNS pathogen, B. burgdorferi. As shown in Figure 22, i.c. administration of 
B. burgdorferi (1x106 organisms) is associated with a significant increase in TNF-α levels 
in whole brain homogenates. Importantly, B. burgdorferi administration failed to elicit 
significant elevations in TNF-α levels in NOD2-/- animals. These results indicate that 
NOD2 plays an important role in the generation of in vivo inflammatory responses to 
these bacterial pathogens. 
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5.3 Conclusions 
 
 A number of studies, conducted by our group as well as others, suggest that 
resident glial cells play an important role in the initiation and progression of 
inflammation following infection or trauma. Microglia and astrocytes are major glial cell 
types present within the CNS and, upon exposure to microbial pathogens, assume 
important effector functions. Studies have demonstrated that both microglia and 
astrocytes have the ability to produce key inflammatory cytokines including TNF-α and 
IL-6 (Kiefer et al. 1993; Streit et al. 1999; Kielian et al. 2002; Rasley et al. 2002a; 
Kielian 2004b; Rasley et al. 2004b). In order to accomplish this role, microglia and 
astrocytes utilize microbial pattern recognition receptors to perceiv  bacterial pathogens 
and to initiate protective, as well as damaging, CNS inflammation.  Indeed, these cell 
types have been shown to functionally express members of the Toll-like family of pattern 
recognition receptors (Lieberman et al. 1989; Dong and Benveniste 2001; Bsibsi et al. 
2002; Bowman et al. 2003; Esen et al. 2004; Olson and Miller 2004; Carpentier et al. 
2005; Esen and Kielian 2005; Kielian et al. 2005a; Oh et al. 2005).  Additionally, we 
have demonstrated that microglia and astrocytes express members of the NOD-like 
family of pattern recognition receptors (see Chapter 3 and 4). 
NLR proteins such as NOD2 have been identified as cytosolic pattern recognition 
receptors that play a role in the initiation of inflammatory host immune responses to 
bacterial challenge (Girardin et al. 2003a; Girardin et al. 2003b; Girardin et al. 2003e; 
Ting and Davis 2005; Strober et al. 2006).  NOD2 appears to function as an intracellular 
receptor for a minimal motif common to all bacterial peptidoglycans (Girardin et al. 
2003b; Girardin et al. 2003e; Takada and Uehara 2006).  We have characterized the 
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expression of NOD2 in primary cultures of murine glial cells and demonstrated hat 
microglia and astrocytes not only express NOD2 and its downstream effector molecule 
Rip2 kinase constitutively, but that expression of these molecules is upregulated in glial 
cells following bacterial challenge (See Chapter 3 and 4). However, the importance of 
NLR proteins in the generation of inflammatory host responses to bacterial pathogens 
within the brain has not been established.  
In this study, we demonstrate that exposure of microglia and astrocytes to 
bacterial lysates increases the association between NOD2 and Rip2 kinase. In addition, 
we have confirmed our previous findings using BALB/c derived cells, by demonstrati g 
that MDP augments the TLR-induced inflammatory responses of microglia and 
astrocytes derived from C57BL/6 mice. Importantly, we have confirmed that these effects 
are mediated by NOD2, rather than other putative receptors for MDP such as NLRP3 
(Martinon et al., 2004), by demonstrating that the ability of MDP to exacerbate responses 
to TLR ligands is abolished in cells derived from NOD2-/- animals (Martinon et al.
2004). Perhaps more importantly, we have assessed the relative importance of NOD2 in 
the immune responses of isolated cultures of primary glia cells to bacterial antigens from 
two disparate and clinically relevant bacterial pathogens of the CNS, N. meningitidis and 
B. burgdorferi. We show that the inflammatory responses of both astrocytes and 
microglia are significantly reduced in the absence of NOD2 expression. Finally, we have 
established the in vivo relevancy of our in vitro studies by studying the CNS 
inflammation associated with direct i.c. bacterial administration in wild-type animals and 
mice genetically deficient in the expression of NOD2. Our data indicate that increases in 
inflammatory cytokine levels within the CNS associated with bacterial infection are 
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reduced in the absence of NOD2 expression. These studies indicate that NOD2 represents 
an important component in the generation of damaging CNS inflammation following 
bacterial infection.  
Interestingly, there does not appear to be marked differences between the 
responses of microglia to N. meningitidis or B. burgdorferi antigens in the presence or 
absence of NOD2. However, astrocytes challenged with B. burgdorferi exhibit more 
NOD2/Rip2 kinase association and higher production of both IL-6 and TNF-α than cells 
exposed to N. meningitidis. As B. burgdorferi has been shown to initiate TLR2- and 
TLR5-mediated innate immune responses (Shin et al. 2008), while N. m ningitidis can 
elicit TLR2 and TLR4-mediated responses (Zughaier et al. 2005; Hellerud et al. 2008), it 
is tempting to suggest that the TLR5/NOD2 interaction might elicit a more robust 
response in astrocytes than that associated with TLR4/NOD2 signaling. While 
verification of such a hypothesis will require further study, it is interesing to note that the 
TLR5 ligand, flagellin, elicits higher inflammatory cytokine production by astrocy es 
when co-administered with MDP than a combination of LPS and MDP (see Figure 19).  
To date, the mechanisms underlying TLR and NOD2 interaction/synergy have yet 
to be determined, but it is probable that crosstalk exists between these disparate pattern 
recognition receptors and recent studies have focused on this issue (Kim et al. 2008).  We 
have demonstrated that ligands such as Pam3Cys (TLR2), LPS (TLR4), flagellin (TLR5), 
and a TLR9-activating CpG oligonucleotide can all augment NOD2 and Rip2 kinase 
protein expression in both microglia (Chapter 4) and astrocytes (Chapter 3). Clearly, the 
interaction between these pattern recognition receptor families requires additional study 
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and experiments to determine the mechanisms underlying TLR and NOD2 interact on/ 
synergy in glial cells are ongoing in our laboratory.  
While it is readily apparent that the MDP-associated exacerbation of glial 
responses to TLR ligands are absent in NOD2-/- derived cells and the responses of these
cells to bacterial lysates are lower than those seen in wild-type–derived cells, it is 
interesting to note that NOD2-/- glial cells demonstrated greater cy okine responses to 
TLR ligands than wild-type–derived cells. Similarly, we observed that uninfected NOD2-
/- mice exhibited higher basal cytokine levels than their wild-type counterpar s. At 
present we cannot explain these findings, but it is conceivable that an endogenous ligand 
for NOD2 might exist that serves to limit TLR-mediated inflammatory responses rather 
than exacerbate them. Further studies will be required to resolve this issue. Taken 
together, the present studies indicate that NOD2 acts in a co-operative manner with 
disparate TLR homologues in the induction of inflammatory cytokine responses of 
primary microglia and astrocytes. In addition, we have shown that NOD2 is required for 
maximal in vitro inflammatory responses of resident CNS cells to bacteril lysates. As 
such, we have identified NOD2 as an important component in the generation of damaging 
CNS inflammation following bacterial infection.
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5.4 Figures 
 
Figure 17: Association of NOD2 with Rip2 kinase in murine microglia and astrocytes 
increases following challenge with bacterial antigens. Primary murine microglia and 
astrocytes (2x106 per well) were untreated (0) or exposed to N. meningitidis (Nm: 1 and 5 
µg/mL) or B. burgdorferi (Bb: 1, 5, and 10 µg/mL) antigens. At 2 h following bacterial 
challenge, protein isolates were immunoprecipitated with antibodies directed against 
Rip2 kinase or NOD2 and subsequently analyzed by denaturing immunoblot for the 
presence of NOD2 (upper panel) or Rip2 kinase (lower panel), respectively. These 
experiments were performed three times with similar results. 
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Figure 18: MDP augmentation of inflammatory cytokine production by stimulated 
microglia is mediated by NOD2. Cells (2x106) from wild-type (NOD2+/+) and NOD2-
knockout (NOD2-/-) animals were untreated (0) or exposed to bacterial flagelin (Flg) or 
LPS (1, 5, and 10 ng/mL in the presence or absence of MDP (5 µg/mL). At 12 h 
following bacterial challenge, culture supernatants were assayed for the p esence of IL-6 
(A and B) and TNF-α (C and D) by specific capture ELISA. Data are presented as the 
mean of triplicate determinations of samples from three separate experiments +/- SEM. 
Asterisks indicate statistically significant differences between cytokine levels in the 
absence or presence of MDP. 
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Figure 19: MDP augmentation of inflammatory cytokine production by stimulated 
astrocytes is mediated by NOD2. Cells (2x106) from wild-type (NOD2+/+) and NOD2-
knockout (NOD2-/-) animals were untreated (0) or exposed to bacterial flagelin (Flg) or 
LPS (1, 5, and 10 ng/mL in the presence or absence of MDP (5 µg/mL). At 12 h 
following bacterial challenge, culture supernatants were assayed for the p esence of IL-6 
(A and B) and TNF-α (C and D) by specific capture ELISA. Data are presented as the 
mean of triplicate determinations of samples from three separate experiments +/- SEM. 
Asterisks indicate statistically significant differences between cytokine levels in the 
absence or presence of MDP. 
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Figure 20: Inflammatory cytokine responses of microglia to N. meningitidis and B. 
burgdorferi are significantly lower in the absence of NOD2 expression. Cells (2x106) 
from wild-type (NOD2+/+) and NOD2- knockout (NOD2-/-) animals were untreated or 
exposed to either B. burgdorferi antigens (Bb: 1, 5, and 10 µg/mL) or N. meningitidis 
antigens (Nm: 1, 5, and 10 µg/mL). At 12 h following bacterial challenge culture 
supernatants were isolated and assayed for the presence of IL-6 (A and B) or TNF-α (C 
and D) by specific capture ELISA. Data are presented as the mean of triplicate 
determinations of samples from three separate experiments +/- SEM. Asterisks indicate 
statistically significant differences in cytokine production between cells derived from 
wild-type and NOD2-deficient animals. 
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Figure 21: Inflammatory cytokine responses of astrocytes to N. meningitidis and B. 
burgdorferi are significantly lower in the absence of NOD2 expression. Cells (2x106) 
from wild-type (NOD2+/+) and NOD2- knockout (NOD2-/-) animals were untreated or 
exposed to either B. burgdorferi antigens (Bb: 1, 5, and 10 µg/mL) or N. meningitidis 
antigens (Nm: 1, 5, and 10 µg/mL). At 12 h following bacterial challenge culture 
supernatants were isolated and assayed for the presence of IL-6 (Panel A) or TNF-α 
(Panel B) by specific capture ELISA. Data are presented as the mean of triplicate 
determinations of samples from three separate experiments +/- SEM. Asterisks indicate 
statistically significant differences in cytokine production between cells derived from 
wild-type and NOD2-deficient animals. 
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Figure 22: Inflammatory cytokine production is markedly reduced in the absence of 
NOD2. Panel A: Wild-type C57BL/6 mice were given vehicle (0) or were infected with 
N. meningitidis (Nm) or B. burgdorferi (Bb) (1x106) via intracerebral injection. Panel B: 
NOD2-/- C57BL/6 mice were given vehicle (0) or were infected with N. meningitidis 
(Nm) or B. burgdorferi (Bb) (1x106) via intracerebral injection. At 72 h post infection 
tissue homogenates were isolated for measurement of TNF-α protein expression by 
specific capture ELISA. Asterisk indicates significant difference from uninfected 
animals. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6: REPLICATION-DEPENDENT IMMUNE RESPONSE OF MICROGLIA 
AND ASTROCYTES TO VESICULAR STOMATITIS VIRUS 
 
 
6.1 Rationale 
 
Vesicular stomatitis virus (VSV) is a nonsegmented negative-strand RNA virus of 
the family Rhabdoviridae, order Mononegavirales.  Members of this order include many 
medically important pathogens including the lethal rabies, Ebola, Marburg, Nipah and 
Hendra viruses. VSV has limited human pathogenicity, despite similarities to other 
Mononegavirales, making it an attractive model for the study of other viruses in this 
order.  As described in work by Dr. Carol Reiss and others (Miyoshi et al. 1971; Lundh et 
al. 1987; Lundh 1990; Bi et al. 1995), intranasal inoculation of VSV leads to infection of 
the olfactory bulb via the olfactory neurons and subsequently leads to infection 
throughout the central nervous system (CNS).  This infection is associated with acute 
encephalitis, breakdown of the blood-brain barrier, and a high degree of mortality similar
to that seen with rabies infections (Huneycutt et al. 1993).  Interestingly, VSV-associated 
encephalitis appears to be T-cell independent (Frei et al. 1989).  This observation and the 
rapidity of the response suggest a role for resident CNS cells in the initiatio  and/or 
progression of this deadly CNS inflammation. While previous studies have demonstrated 
that neurons are readily infected by VSV (Bi et al. 1995), the susceptibility of other glial 
cell types to infection with this virus remains unclear.  
Microglia and astrocytes are resident glial cells of the CNS and are i eally 
situated to detect and respond to viral pathogens.  Upon activation, these cells assume 
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immune effector functions that include inflammatory mediator production and MHC 
class II molecule expression (Hickey and Kimura 1988; Hatten et al. 1991; Kiefer et al. 
1993; Benveniste 1997a; Soos et al. 1998; Streit et al. 1999; Owens et al. 2005).  
Importantly, microglia and astrocytes appear to respond to VSV as the encephalitis 
caused by this virus is associated with proliferation of these cell types and increased 
MHC class II molecule expression on their surfaces (Bi et al. 1995).  Recent studies from 
our laboratory have shown that microglia and astrocytes express retinoic acid- nducible 
gene-I (RIG-I) and melanoma differentiation-associated gene-5 (MDA5) (Furr et al. 
2008), two members of the (RIG-I)-like receptor (RLR) family of cytosolic proteins that 
can serve as intracellular pattern recognition receptors for replicative RNA virus motifs 
(Meylan and Tschopp 2006; Takeuchi and Akira 2007).  Interestingly, the level of 
expression of these receptors was upregulated in microglia and astrocytes f llowing 
exposure to VSV, consistent with a functional role for RLRs in virally-induced immune 
responses by these resident CNS cells (Furr et al. 2008).  However, the ability of VSV to 
infect and replicate within these glial cells has not been established. 
In the present study, we demonstrate that primary murine microglia and astrocytes 
are permissive for VSV infection both in vitro and in vivo.  Furthermore, we show that 
active replication of this virus appears to be required for robust inflammatory mediator 
production by these resident CNS cell types.  These data suggest that viral replic tion 
within resident glial cells plays a key role in the development of lethal CNS inflammation 
following neurotropic Mononegavirales infection. 
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6.2 Results 
 
Mononegavirales infect and replicate within primary murine microglia and 
astrocytes 
 
 To directly examine the ability of VSV to infect and replicate in astrocy es and 
microglia, we isolated primary glial cells from neonatal C57BL/6 mice using protocols 
established in our laboratory (Harry et al. 1998; Rasley et al. 2002a; Rasley et al. 2002b).  
After two weeks in culture, astrocytes and microglia were isolated from these mixed glial 
preparations and the purity of the cell populations were confirmed by 
immunofluorescence microscopy as described in the Materials and Methods section.  To 
directly assess the ability of VSV to infect and replicate within these isolated glial cells 
we have employed a recombinant VSV containing the GFP gene (VSV-GFP) 
incorporated between the viral G and L genes (Figure 23B).  Due to the negative-sense 
polarity of the VSV RNA genome and the distant position of the GFP gene from the 3’-
end of the genomic RNA, GFP expression is only detectable following successful VSV-
GFP replication within target cells.  As shown in the fluorescence micrographs in Figure 
24A, GFP-associated fluorescence attributable to VSV-GFP replication was readily 
detectable in both astrocyte and microglia cultures at 24 hours following viral challenge.  
The maximal GFP-associated fluorescence intensity was observed in astrocytes infected 
with VSV-GFP at an MOI of 10 (Figure 24A).  Interestingly, maximal GFP-associated 
fluorescence intensity was observed in microglia at an MOI of only 1.  While the reason 
for this difference is unclear, it is most likely attributable to decreased microglia viability 
as evidenced by morphological changes (data not shown) and our previous demonstration 
that cellular protein expression is decreased when these cells are exposed to high VSV 
titers (Furr et al. 2008).  We have verified these findings by immunoblot analysis for the 
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presence of GFP in infected glial cells.  As shown in Figure 24B, the levels of VSV-
directed GFP expression in both astrocytes and microglia mirrored the resultsobtained 
using fluorescence microscopy with maximal expression of GFP in astrocytes infected 
with an MOI of 10 and a maximal expression of GFP in microglia infected at an MOI of 
1.  In addition, we performed parallel studies utilizing wild type VSV in which astrocytes 
and microglia were infected in vitro and the presence of viral products were determin d 
in whole cell protein isolates by immunoblot analysis.  We report that both microglia and 
astrocytes demonstrated cellular accumulation of VSV N and P-proteins at 24 hours p.i. 
(data not shown). 
 To determine whether the ability of VSV to replicate within resident CNS cells is 
specific for this neurotropic RNA virus, microglia and astrocytes were exposed to the 
paramyxovirus, Sendai virus (SeV), a Mononegavirales that is distantly related to VSV 
and lacks the ability to cross the blood-brain barrier (Lundh et al. 1987).  Primary murine 
glial cells were exposed to recombinant SeV containing the GFP gene (SeV-GFP, Fig. 
23D) and viral infection and replication was again assessed by fluorescence microscopy 
and immunoblot analysis.  As shown in Figure 24C, SeV-associated GFP fluorescence 
was readily detectable in both astrocytes and microglia at 24 hours post infection (p.i.). 
Fluorescence intensity increased according to the initial number of infectious viral 
particles introduced (Figure 24C) and this observation was confirmed by immunoblot 
analysis for cellular GFP expression (Figure 24D).  These data demonstrate the ability of 
SeV to infect murine glial cells and suggest that astrocytes and microglia are permissive 
for infection by both neurotropic and non-neurotropic Mononegavirales. 
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Primary murine microglia and astrocytes respond to Mononegavirales infection by 
secreting key inflammatory mediators 
 
Previous studies have indicated that resident CNS cell types respond to the 
presence of VSV by the expression of MHC class II molecules and production of NO (Bi 
et al. 1995).  However, it is not clear whether these effects occur as a consequence of 
viral recognition by glial cells or as a secondary response to inflammatory mediators 
and/or damage-associated molecules released by infected neurons.  To directly assess the 
ability of glial cells to respond to VSV we have utilized specific capture ELISAs to 
quantify the production of key inflammatory cytokines by isolated cultures of primary 
murine microglia and astrocytes following infection with VSV.  As shown in Figure 25A, 
microglia produce significant levels of both IL-6 and TNF-α, cytokines known to be 
produced at high levels during viral encephalitis (Nuovo et al. 2005; Rempel et al. 2005), 
in response to wild type VSV at 12 and 24 hours p.i..  Maximal cytokine responses in 
microglia were observed at viral MOI of 0.1 and 1 at 12 and 24 hours p.i., respectively 
(Figure 25A), with higher viral titers resulting in lower production consistent with cell 
death at these MOIs.  Similarly, astrocytes also produced significant levels of IL-6 and 
TNF-α at 12 and 24 h following infection with VSV (Figure 25B).  
 To determine whether these responses were specific for the neurotropic virus 
VSV, we have performed similar experiments to determine the cytokine responses of 
microglia and astrocytes to SeV infection.  As shown in Figure 26, both microglia and 
astrocytes produced significant levels of IL-6 and TNF-α in response to SeV-GFP at both 
12 and 24 hours p.i..  These responses increased according to the numbers of infectious 
viral particles introduced to the glial cultures (Figure 26).  Interestingly, while SeV also 
elicited significant cytokine responses, the levels of IL-6 and TNF-α produced by SeV-
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infected glial cells were substantially lower than those observed for comparable numbers 
of infectious VSV particles (Figure 25). 
Viral replication is required for robust microglia and astrocyte immune responses 
to VSV  
 
 While it is apparent that glial cells can directly respond to VSV infection, it is 
unclear whether these cells respond to external/internalized viral particles or if viral 
replication is a prerequisite for microglia and astrocyte immune responses.  To begin to 
address this question, we have performed experiments employing heat-inactivated VSV.  
While exposure of microglia or astrocytes to heat-inactivated wild type VSV resulted in 
production of detectable levels of both IL-6 and TNF-α (Figure 27), it is important to 
note that such inflammatory cytokine production was approximately 10-fold lowerthan 
that observed following infection with viable VSV (Figure 25). 
 To further address the question of whether viral replication is required for robust
inflammatory mediator production by infected glial cells we have performed parallel 
experiments utilizing a host-range VSV mutant, HR1-1 (Figure 23C), developed by our
laboratory (Grdzelishvili et al. 2005; Grdzelishvili et al. 2006) that can infect cells but 
demonstrates severely impaired replication in most cell types.  The VSV HR1-1 mutant 
has a single nucleotide substitution resulting in a mutant L protein with a D to V 
substitution at position 1671.  We have shown that the D1671V L mutation completely 
eliminates viral mRNA cap methylation at both the guanine-N7 and 2’-O-adenosine 
positions (Grdzelishvili et al. 2005; Grdzelishvili et al. 2006) and results in subsequent 
non-translatability of primary VSV transcripts (Horikami and Moyer 1982; Hercyk et al. 
1988; Horikami et al. 1992; Grdzelishvili et al. 2005; Grdzelishvili et al. 2006).  As a 
result, VSV HR1-1 displays a host-range (hr) phenotype characterized by severely 
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restricted growth in most cell types lines but normal replication in a very limited number 
of “permissive” cells including BHK-21 cell line, which was used to produce this mutant 
virus (Grdzelishvili et al. 2005; Grdzelishvili et al. 2006).  As shown in Figure 28, 
exposure of microglia or astrocytes to VSV HR1-1 results in detectable production of 
inflammatory cytokines but such production was again 10-fold lower than that observed 
following exposure to comparable numbers of infectious wild type VSV particles (Figure 
25).  Taken together, these data demonstrate that active viral replication is required for 
robust immune responses of infected glial cells. 
Intranasal administration of VSV results in murine glial cell infection in situ 
To confirm the ability of VSV to infect glial cells in situ we have employed an 
established murine model of virally-induced encephalitis (Bi et al. 1995).  Wild type 
VSV was introduced via intranasal administration to 3-4 week old male C57BL/6 mice.  
As shown in Figure 29A, VSV inoculated animals rapidly developed symptoms 
associated with CNS infection as assessed by disease severity scoring in co trast to mice 
that received inoculation with vehicle alone.  Animals were sacrificed at 4 days p.i. and 
whole brains were isolated in such a way as to avoid possible contamination with any 
residual viral particles that might be present in the olfactory canal.  Brain tissue was 
homogenized and viral product expression and infectious viral particle content was 
quantified by immunoblot analysis and plaque assay, respectively.  As shown in Figure 
29B, the N, P, M and G proteins of VSV were detectable in whole brain protein isolates 
as determined by immunoblot analysis using a polyclonal antibody directed against VSV.  
In addition, we have performed plaque assays using BHK cells to confirm the presence of 
infectious particles in the CNS at 4 days p.i. (data not shown).  Finally, we have 
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confirmed the development of infection within the CNS following intranasal VSV 
administration by direct quantification of pro- and anti-inflammatory mediators in whole 
brain homogenates by specific capture ELISAs.  As shown in Figure 29C, VSV infectio  
resulted in marked increases in levels of the pro-inflammatory cytokine, IL-6. 
Interestingly, this elevation was associated with a concomitant decrease in lev ls of the 
immunosuppressive cytokine, IL-10, in infected brain tissue (Figure 29C).  Together, 
these data confirm that intranasal VSV administration leads to establishment of brain 
tissue infection and results in CNS inflammation. 
Importantly, we have performed experiments to determine whether resident glial 
cells are infected in situ following intranasal VSV administration.  To accomplish this 
goal, glial cells were purified from infected whole brain tissue homogenates by Percoll 
gradient and the presence of VSV structural proteins was determined by immunoblot 
analysis.  As shown in Figure 29B, N, P, M and G proteins of VSV were readily 
detectable in glial cell protein isolates.  To independently confirm this result we have 
again utilized our recombinant VSV-GFP virus (Figure 23).  Mice received intranasal 
viral inoculations and at 5 days p.i. enriched microglia cell populations were prepared by 
density gradient purification.  The identity of these myeloid cells was verified by the cell 
surface expression of CD11b by flow cytometry.  Importantly, we have been able to 
simultaneously analyze these cells for the presence of GFP fluorescence asso iated with 
replicating VSV.  As shown in Figure 29D, we have determined that 12% of the total cell 
population was dual positive for the microglia marker CD11b and viral GFP, and this 
corresponds to 20% of the total CD11b-positive population.  Taken together, these in 
vivo studies support the results obtained in isolated glial cultures and indicate that 
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resident non-neuronal CNS cells can be infected by VSV in situ following intranasal 
infection and, importantly, can support viral replication. 
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6.3 Conclusions 
 
The order Mononegavirales consists of viruses containing a non-segmented, 
negative-sense RNA genome and includes the causative agents for a number of 
established (rabies, measles, mumps) and emerging (Ebola, Borna, Hendra, Nipah) 
human diseases (Pringle 1997).  Some members of this order, such as rabies and 
Newcastle disease virus, have the ability to circumvent the blood-brain barrier to 
establish CNS infection resulting in a severe and often fatal inflammation of brain tissue 
(Seal et al. 2000; Leung et al. 2007).  VSV has the ability to infect neurons and generate 
acute encephalitis in mice in a manner that closely resembles rabies (Huneycutt et al. 
1993) and has therefore proved to be a useful model for Mononegavirales that cause 
lethal human CNS infections.  Like rabies virus, VSV-associated CNS inflammation is 
rapid, occurring within days of intranasal inoculation (Huneycutt et al. 1993).  This rapid 
onset is indicative of an innate immune response and is likely to involve the activation of 
resident CNS cells that have immune functions.  Such a hypothesis is supported by the 
observation that VSV-associated encephalitis is unaltered in athymic mice sugg sting that 
this inflammatory immune response is T-cell independent (Frei et al. 1989).  
Furthermore, several studies have indicated that resident CNS cells exhibit immune 
functions in situ following VSV infection (Huneycutt et al. 1993; Bi et al. 1995; Christian 
et al. 1996). 
There is growing appreciation that microglia and astrocytes play an important role 
in the generation of protective immune responses or progressive inflammatory d mage 
following CNS infection.  These cells are activated by a variety of microbial pathogens 
including viruses and assume immune effector functions such as the production of 
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inflammatory mediators and the expression of MHC class II molecules (Bi et al. 1995; 
Taylor et al. 2003; Rasley et al. 2004a).  Studies conducted in the laboratory of Dr. Carol 
Reiss (Bi et al. 1995) have demonstrated that microglia and astrocytes respond to VSV 
infection by proliferation, production of iNOS, and the induction of cell surface MHC 
class II molecule expression.  Such responses are likely to set the stage for subsequent 
inflammatory damage (Schwartz et al. 1999).  While it is possible that these glial cells 
can directly recognize viral motifs via cell surface pattern recogniti n receptors or may 
respond to inflammatory mediators or other "danger signals" released from in ected 
neurons following lytic damage, the mechanisms underlying Mononegavirales activation 
of resident CNS cells have not been determined. 
In the present study, we demonstrate that VSV replication products can be 
detected in isolated cultures of primary murine microglia and astrocytes following in 
vitro viral challenge.  In addition, we have shown that these products can be detected in 
glial cells isolated from the brains of mice inoculated with VSV intranaslly.  We have 
utilized recombinant GFP gene containing VSV to establish that the presence of viral
products within glia is not attributable to adhesion of viral particles to the plasma 
membrane or their internalization by phagocytosis.  Finally, we have demonstrated that 
VSV replication in microglia or astrocytes precipitates inflammatory cytokine production 
by these resident CNS cell types.  These findings are consistent with the previously 
documented in situ activation of glial cell following in vivo VSV infection (Bi et al. 
1995; Christian et al. 1996).  The relevancy of these findings to human Mononegavirales 
CNS infections is supported by the ability of rabies virus to infect cultured microglia and 
astrocytes (Ray et al. 1997).  In addition, we have shown that the susceptibility of murine 
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microglia and astrocytes to infection is not restricted to rhabdoviruses as these cells can 
be infected with and support the replication of SeV, a paramyxovirus, (Lundh et al. 
1987).  Furthermore, we show that glial cells respond to SeV infection by inflammatory 
cytokine production, albeit with smaller responses to those seen with VSV.  As such, 
these data suggest that glial cells have a broad susceptibility to Mononegavirales and can 
respond to members of this order by changes in the production of immune molecules that 
can promote damaging CNS inflammation. 
Interestingly, we have also demonstrated that viral replication is required to elicit 
robust immune responses by microglia and astrocytes.  We show that heat inactivated 
wild type VSV elicits glial immune responses that are an order of magnitude lower than 
that induced by infectious viral particles.  These results suggest that VSV-associated 
inflammatory responses are not predominantly mediated by cell surface and/or 
endosomal microbial pattern recognition receptors such as TLR3 or TLR7.  Such a 
hypothesis is further supported by our experiments employing the host-range VSV HR1-
1 mutant which is replication impaired in glial cells (Grdzelishvili et al. 2005; 
Grdzelishvili et al. 2006) and fails to elicit marked inflammatory cytokine production by 
microglia or astrocytes.  This result indicates that active viral replication is a critical 
requirement for the generation of glial immune responses to this Mononegavirales.  
While this effect cannot be adequately explained by the perception of viral partic es by 
TLRs present on glial cells (Konat et al. 2006), the recent demonstration that microglia 
and astrocytes express members of the newly described RLR family may provide a 
mechanism underlying the replication-dependent nature of these responses  (Furr et al. 
2008).  RLRs are present in the cytosol of many cell types and have been shown to 
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function as intracellular sensors for replicative viral RNA motifs (Meylan and Tschopp 
2006; Takeuchi and Akira 2007).  Interestingly, recent studies suggest that the RLR, 
RIG-I, demonstrates specificity for VSV and SeV RNA (Yoneyama et al. 2004; 
Yoneyama et al. 2005; Kato et al. 2006; Hiscott 2007) and we have demonstrated that 
both microglia and astrocytes constitutively express this intracellular receptor (Furr et al. 
2008).  Furthermore, we have shown that such expression is rapidly elevated in murine 
glial cells following infection with either VSV or SeV (Furr et al. 2008).  As such, the 
replication-dependent nature of microglia and astrocyte responses to VSV described in 
the present study provides circumstantial evidence for the importance of RIG-I in the 
generation of inflammatory cytokine production by glial cells. 
Taken in concert, these studies support a scenario in which neurotropic 
Mononegavirales can invade the CNS and infect both neuronal and non-neuronal cell 
types.  While neurons are well known to support viral replication, our data indicates that 
microglia and astrocytes are also permissive for M nonegavirales replication.  
Importantly, the generation of replicative viral RNA can subsequently be perceived by 
intracellular pattern recognition receptors such as RIG-I, known to be expressed by both 
astrocytes and microglia.  The resulting activation of RIG-I-dependent sig aling 
pathways could then initiate glial cell immune functions, precipitating the leal 
inflammation associated with Mononegavirales CNS infections. 
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6.4 Figures 
 
 
 
Figure 23: The organization of negative-sense RNA genomes of the recombinant viruses 
used in the present study.  The viral RNA dependent RNA polymerase (consisting of L 
and P proteins) sequentially synthesizes mRNAs in the order that they appear from the 3’ 
end of the genome. Initiation of each downstream gene occurs sequentially as the 
polymerase pauses at the intergenic junction and then reinitiates synthesis of the next 
gene. Panel A: Recombinant wt VSV (Indiana serotype) genomic RNA.  Panel B: 
Recombinant wt VSV (Indiana serotype) encoding GFP as an extra gene between G and 
L genes Panel C: Recombinant VSV (Indiana serotype) HR1-1 mutant with a mutation 
resulting in an L protein with a single substitution D to V at L amino acid position 1671.  
Panel D: Recombinant SeV (Fushimi strain) with GFP as an extra gene upstream of the 
NP gene.  SeV-GFP does not require trypsin in the medium as it has a wt monobasic 
trypsin-dependent cleavage site in the F protein mutated to an oligobasic cleavage site, 
allowing F activation in any cell type through a ubiquitous furin-like protease.  
(Designed by Dr. Valery Grdzelishvili) 
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Figure 24: VSV and SeV infect and replicate within primary murine microglia and 
astrocytes. Cells (1 X 106) were untreated or infected with VSV-GFP (Panels A and B) or 
SeV-GFP (Panels C and D) and cultured for a period of 24 hours.  Panels A and C: Cells 
were imaged for the expression of GFP by fluorescence microscopy.  Panels B ad D: 
Whole cell protein lysates were prepared and GFP expression determined by Western 
blot analysis.  One representative blot from three separate experiments is shown.
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Figure 25: Primary murine microglia and astrocytes produce inflammatory mediators 
following infection with wt VSV.  Microglia (Panel A) and astrocytes (Panel B) were 
uninfected or exposed to wt VSV. At 12 and 24 hours p.i., culture supernatants were 
assayed for the presence of IL-6 or TNF-α by specific capture ELISA.  Data are 
presented as the mean of duplicate measurements of samples from at least thre  separate 
experiments ± SEM.  Asterisks indicate a statistically significant difference from 
uninfected cells. 
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Figure 26: Primary murine microglia and astrocytes produce inflammatory mediators 
following exposure to SeV-GFP.  Microglia (Panel A) and astrocytes (Panel B) were 
uninfected or exposed to SeV-GFP.  At 12 and 24 hours p.i. culture supernatants were 
assayed for the presence of IL-6 or TNF-α by specific capture ELISA.  Data are 
presented as the mean of duplicate measurements of samples from at least thre  separate 
experiments ± SEM.  Asterisks indicate a statistically significant difference from 
uninfected cells.  
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Figure 27: Heat inactivation attenuates VSV-induced inflammatory mediator production 
by primary murine microglia and astrocytes.  Microglia (Panel A) and astrocytes (Panel 
B) were untreated or exposed to heat-inactivated wt VSV.  At 12 and 24 hours p.i., 
culture supernatants were assayed for the presence of IL-6 or TNF-α by specific capture 
ELISA. Data are presented as the mean of duplicate measurements of samples from at 
least three separate experiments ± SEM.  Asterisks indicate a statistically ignificant 
difference from uninfected cells. 
 113
 
 
Figure 28:  Exposure of primary murine microglia and astrocytes to a replication-
impaired VSV HR1-1 mutant elicits only modest inflammatory mediator production.  
Microglia (Panel A) and astrocytes (Panel B) were uninfected or infected with VSV 
HR1-1 mutant.  At 12 and 24 hours p.i. culture supernatants were assayed for the 
presence of IL-6 or TNF-α by specific capture ELISA.  Data are presented as the mean of 
duplicate measurements of samples from at least three separate experim nts ± SEM.  
Asterisks indicate statistically significant difference from uninfected cells.  
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Figure 29: VSV infects microglia and astrocytes in situ following intra asal 
administration. C57BL/6 mice were inoculated intranasally with 2 X 107 PFUs of wt 
VSV (Panels A to C) or VSV-GFP (Panel D).  At 5 days post-infection, disease sverity 
was assessed according to appearance and behavior and is reported as a severity score for 
each animal (Panel A).  Severity was scored from 1 (no detectable behavioral diffe ences) 
to 5 (moribund).  Asterisk indicates a moribund animal that was euthanized prior to day 
5.  Panel B: Protein isolates from whole brain (Brain) or density gradient purified glial 
cells (Glia) were analyzed for the presence of VSV products by immunoblot analysis.  
Plus sign represents a positive control with protein isolates prepared from purified VSV 
virions.  Panel C: Levels of IL-6 and IL-10 were quantified in whole brain homogenates 
by specific capture ELISA.  Panel D: Density gradient purified glial cells were analyzed 
for the percentage of cells co-expressing the microglia/macrophage cell marker CD11b 
and VSV-associated GFP by flow cytometry.  Asterisk indicates statistic lly significant 
difference from uninfected cells (0).  Non-specific staining was determin d using 
antibodies directed against irrelevant antigens and is indicated (Irr). 
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CHAPTER 7: DISSERTATION SUMMARY 
 
 
There is growing appreciation for the role of resident glial cell in the gen ration of 
inflammation, both damaging and protective, during central nervous system infection.  
Studies have demonstrated that microglia and astrocytes, major glial cell types within the 
brain, have the ability to perceive microbial pathogens and subsequently assume effector 
functions to recruit and activate infiltrating leukocytes (Hickey and Kimura 1988; Hatten 
et al. 1991; Kiefer et al. 1993; Benveniste 1997a; Soos et al. 1998; Streit et al. 1999; 
Owens et al. 2005).  In order to accomplish these tasks, microglia and astrocytes utilize 
pattern recognition receptors to identify and respond to highly conserved pathogen 
associated molecular patterns.  Previous studies have demonstrated that these resid nt 
glial cells functionally express members of the Toll-like family of pattern recognition 
receptors.  However, the expression of these molecules does not eliminate the possibility 
that other families of pattern recognition receptors may contribute to the activation of 
these cell types.  Furthermore, the expression of TLRs fails to adequately explain 
responses of these cell types to intracellular pathogens within the cytosolic space 
(Laflamme and Rivest 2001; Bsibsi et al. 2002; Rasley et al. 2002a; Bowman et al. 2003; 
Esen et al. 2004; Olson and Miller 2004; Carpentier et al. 2005; Esen and Kielian 2005; 
Kielian et al. 2005a).   
In the present study, we have employed methods to demonstrate that members of 
the NLR family of pattern recognition receptors, specifically NOD1 and NOD2, are 
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present within murine microglia and astrocytes.  The NOD1 and NOD2 molecules 
are cytosolic receptors that have been shown to perceive minimal motifs of bacterial 
peptidoglycans, specifically iE-DAP and muramyl dipeptide, respectively (Chamaillard et 
al. 2003b; Girardin et al. 2003a; Girardin et al. 2003b; Girardin and Philpott 2004).  Our 
investigations have determined that robust levels of NOD2 mRNA and protein are 
expressed constitutively by both microglia (Figures 11B and 13) and astrocytes (Figures 
6 and 8).  There is marked upregulation of NOD2 molecules following exposure to 
antigen preparations of N. meningitidis or B. burgdorferi, two clinically relevant 
pathogens of the CNS (Figures 5, 8A, 11B, and 13A).  Interestingly, viability of the 
bacterium was not a requirement for the upregulation of this molecule.  As such itcan be 
inferred that intracellular infection of microglia and astrocytes by N. meningitidis or B. 
burgdorferi was also not required.  This argues against the maintenance of NOD2 levels 
via an autoregulatory mechanism.  Such a hypothesis is supported by the observation that 
MDP, a known ligand for NOD2 was a relatively poor stimulus in microglia as compared 
to TLR ligands for the upregulation of NOD2 molecules (Figure 12A and 12C).  Certain 
TLR ligands proved to be potent inducers of NOD2 expression (Figures 8B, 12C, and 
3B).  There were, however, differences between microglia and astrocytes in that TLR9 
ligation was unable to induce upregulation in microglia, yet proved to be a sufficient 
stimulus in astrocytes.  Since TLR receptors are found on the cell membrane or within 
endosomal compartments the lack of intracellular bacterial infection would be irrelevant 
in their action.  This is suggestive of TLR-mediated upregulation of the NOD2 receptor, 
an observation which is consistent with other studies highlighting possible cooperation 
between different families of pattern recognition receptors.  To confirm th s hypothesis 
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additional studies examining the interactions between TLRs and NOD2 are being 
undertaken by other members of our group.   
Our investigations have also demonstrated constitutive expression of NOD1 
mRNA as well as protein (Figures 5, 7, 11A, and 14).  However, marked differences in 
the levels of these molecules were observed when comparing NOD1 and NOD2 with 
NOD2 being expressed at multiple log scales higher than NOD1 in both microglia and 
astrocytes.  Like NOD2, NOD1 expression was increased following exposure t  antigen 
preparations of N. meningitidis and B. burgdorferi, as well as known TLR ligands 
(Figures 5, 7, 11, and 14).  However, the final levels of the NOD1 expression paled in 
comparison to those of NOD2.  This finding is not altogether unexpected as other studies 
have reported a cell-specific preference of expression for the NOD1 and NOD2
molecules.  Indeed, studies have demonstrated that macrophages preferentially express 
NOD2 while intestinal epithelial cells express NOD1 almost exclusively (Strober et al. 
2006).  Our finding is suggestive of NOD2 serving a potentially more important role than 
NOD1 in the perception of bacterial pathogens by these resident glial cell types.  
Therefore, we elected to focus our investigation specifically on the role of th  NOD2 
pathway in the generation of inflammation by microglia and astrocytes.  Although it is 
likely that later studies by our group will investigate the possible role of NOD1 in these 
resident glial cells.   
The activation of the NOD2 pathway begins with the interaction between 
muramyl dipeptide and the leucine-rich repeat region of the NOD2 receptor.  In a resting
state the protein is negatively regulated by this leucine rich region and, upon ligand 
binding, undergoes a conformational change allowing oligomerization and interaction 
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with the downstream effector molecule Rip2 kinase.  Rip2 kinase contains a CARD 
domain which allows it to physically associate with oligomerized NOD proteins through 
homophilic CARD-CARD interactions.  Rip2 kinase is then able to interact with the IKK 
complex ultimately leading to the activation of the NFκB complex.  There is also 
evidence to suggest that the MAP kinase cascade is activated although the mechanism is 
not currently understood.  It is obvious from a brief examination of this pathway that 
Rip2 kinase is integral to the action of the NOD2 receptor and it is also equally important 
in the NOD1 pathway (Inohara et al. 1999; Ogura et al. 2001b; Kobayashi et al. 2002).  
Due to this fact our study has also investigated the expression of Rip2 kinase mRNA and 
protein within microglia and astrocytes.  We have demonstrated that there is constitutive 
expression of Rip2 kinase mRNA and protein within both glial cell types. These levels
are markedly upregulated following exposure to antigen preparations from N. 
meningitidis and B. burgdorferi (Figures 9 and 15).  This indicates that microglia and 
astrocytes possess, constitutively, the critical molecular participants in the NOD2 
pathway.  It is important to note that levels of Rip2 kinase expression were markedly 
higher in microglia in comparison to astrocytes, representing a cell-specific difference in 
the expression of this protein.  The observation that Rip2 kinase is upregulated by similar 
stimuli to those observed in NOD2 is an interesting result and may constitute an 
additional mechanism for signal magnification to complement increased receptor 
expression.  Late in our investigation another group of researchers identifie GRIM-19 as 
a possible alternative adapter molecule for the NOD2 receptor and, therefore, we took 
steps to investigate this molecule as part of our microglia study.  As with Rip2 kinase, 
robust GRIM-19 expression was observed in microglia and, in a similar manner, antigen 
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preparations were a sufficient stimulus to elicit marked upregulation of this molecule 
(Figure 15).  It is possible that microglia may use this molecule during NOD2 pathway 
activation.  The identification of this molecule occurred subsequently to the conclusion of 
our astrocyte study and was not included as part of that investigation.   
The demonstration that the NOD2 receptor, as well as the downstream effector 
molecule Rip2 kinase, is present and can be upregulated following stimulation suggests 
of a functional pathway.  However, this evidence is far from conclusive in this matter. 
Additional experiments examining pathway functionality were conducted beginnin with 
the investigation of the influence that NOD2 ligation has upon pro-inflammatory 
cytokine production.  Interestingly, exposure of microglia and astrocytes to MDP alone 
failed to elicit statistically significant production of IL-6 and TNF-α, important cytokines 
that have been associated with inflammatory processes within the CNS (Figures 10 and 
16).  This finding was not considered overly surprising in that previous studies have 
reported that MDP is a relatively poor stimulus, even in dedicated immune cell types 
such as macrophages (Pauleau and Murray 2003).  Additional experiments were 
conducted to evaluate the ability of the NOD2 pathway to augment TLR mediated 
responses.  Microglia and astrocytes were exposed to known ligands for TLR2 (Poly I:C), 
TLR4 (lipopolysaccharide), TLR5 (flagellin), and TLR9 (unmethylated CpG motifs) 
alone and in combination with MDP.  These ligands were chosen based upon previous 
studies indicating the expression of their corresponding receptors in microglia and 
astrocytes.  The results of this experiments indicated that the NOD2 pathway is able to 
augment TLR-mediated production of pro-inflammatory cytokines in a greater th n 
additive manner.  This is indicative of a synergistic relationship between the TLR 
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receptors and the NOD2 pathway.  Additionally, this finding is in agreement with studie  
in other cell types (Pauleau and Murray, 2003) and is consistent with the recent findings 
of Chen et al. showing that NOD2 functions in conjunction with TLR2 to upregulate the 
expression of formyl peptide receptor 2 (mFPR2) (Chen et al. 2008), a G-protein coupled 
receptor that mediates the chemotactic activity of pathogen and host-derived peptides 
including amyloid beta 42, the key causative factor in Alzheimer’s disease.  Similarly, 
another recent study has demonstrated that NOD2 acts in concert with TLRs to induce 
nitric oxide and TNF-α production and to upregulate the expression of P2X4R, an ATP-
regulated ion channel associated with CNS inflammation (Guo et al., 2006).   
Interestingly, this relationship demonstrates a degree of cell specificity. In 
astrocytes MDP was able to augment TLR4, TLR5, and TLR9-mediated production of 
IL-6 and TNF-α in a statistically significant manner (TLR2 was not tested).  In microglia, 
MDP was able to augment TLR2, TLR4, and TLR5-mediated production of IL-6 and 
TNF-α, yet failed to augment TLR9-mediated production.  IL-1β was also examined in 
microglia and displayed some surprising results.  In microglia MDP alone was able to 
elicit cytokine production along with an ability to augment TLR4 and TLR5-mediat d IL-
1β production.  These data serve to highlight important differences between microglia 
and astrocytes in terms of NOD2 and are consistent with some of our previous 
observations.  First, the augmentation of TLR-mediated responses in microglia is gre ter 
in magnitude than those observed in astrocytes.  This is consistent with higher NOD2 
mRNA and protein, as well as higher Rip2 kinase expression, observed in microglia 
relative to astrocytes.  Second, unmethylated CpG motifs were able to elevate NOD2 
expression in astrocytes, but not in microglia.  This is consistent with the inability of 
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NOD2 to augment TLR9-mediated cytokine production in microglia. Finally, MDP is 
able to elicit a modest, yet statistically significant, production of IL-1β which represents a 
cell-specific difference in NOD2 mediated responses between these two cll types.  
While there are marked differences between the responses in microglia and astrocytes, 
the observation that NOD2 ligation can augment TLR-mediated cytokine production 
provides important evidence of functional NOD2 expression.   
Our further experiments focused on providing even more definitive evidence of 
functional NOD2 pathway expression.  To this end we revisited the critical role of Rip2 
kinase in this pathway, in particular to examine the interaction between Rip2 kinase and 
the NOD2 molecule.  If activation of this pathway is occurring then there must be 
interaction between the NOD2 receptor molecule and the downstream effector Rip2 
kinase.  We utilized co-immunoprecipitation to evaluate if, following exposure to antigen 
preparations from N. meningitidis and B. burgdorferi, there were increases in this 
interaction.  Our results indicated that exposure to either these bacterial pr p rations 
resulted in increased association between NOD2 and Rip2 kinase (Figure 17).  These 
results were independently confirmed in additional experiments conducted by Samanth  
Furr, another member of our research group (Chauhan et al. 2009).    
It has been suggested that there may be other receptors for muramyl dipeptide, 
such as NLRP3 (Martinon et al. 2004).  Therefore, in order to determine if the effects we 
have observed can directly be attributed to the NOD2 pathway, we decided to utilize 
siRNA technology to knock down NOD2 protein production.  This course of 
experimentation also allows us to examine the relative contribution of the NOD2 pathway 
to the generation of inflammatory cytokines by microglia and astrocytes.  Unfortunately, 
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this approach proved to be technically challenging and ultimately ineffective for our 
purposes and, as such, was abandoned for the use of commercially available mice 
deficient in the NOD2 protein.  Our initial studies examining the augmentatio  of TLR-
mediated responses by MDP were conducted in microglia and astrocytes derived from the 
Balb/c mouse strain while the NOD2-deficient mice were bred onto a C57Bl/6 
background.  Therefore, in order to insure the appropriate control groups, the initial 
experiments using TLR ligands in combination with MDP were repeated using cells 
derived from the new mouse strain.  In these repeat experiments we utilized the ligands 
for TLR4 and TLR5 due to the demonstrated cooperativity with MDP effects in both 
microglia and astrocytes.  At the same time parallel experiments were conducted in the 
NOD2 deficient mice.  As expected, MDP significantly augmented the TLR4 and TLR5-
mediated production of IL-6 and TNF-α in the wild-type C57Bl/6 microglia and 
astrocytes.  The NOD2 deficient microglia and astrocytes, however, displayed no such 
augmentation (Figures 18 and 19).  This piece of evidence definitively demonstrates that 
the MDP-mediated effects observed in combination with the TLR ligands are due to 
interaction with the NOD2 pathway.  Furthermore, this experiment proves that there is 
functional NOD2 pathway expression in murine microglia and astrocytes.   
The demonstration of functional NOD2 pathway expression leads to the question 
of to what degree that this particular pathway contributes to the generation of 
inflammatory responses in microglia and astrocytes to pathogens.  Therefore, we utilized 
cells derived from NOD2-deficient mice to address this issue.  Our experiments utilizing 
antigen preparations from N. meningitidis and B. burgdorferi demonstrate that, in the 
absence of NOD2 expression, the production of the pro-inflammatory cytokines IL-6 and 
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TNF-α are significantly attenuated (Figures 20 and 21).  This result is consistent between 
microglia and astrocytes and indicates that the NOD2 pathway may represent and 
important mechanism for the generation of inflammatory responses by these cell types.   
In order to translate these results into an in-vivo setting, experiments were 
conducted using an established model of N. meningitidis and B. burgdorferi infection.  
Wild-type or NOD2 deficient mice were uninfected or injected intracerebrally with live 
N. meningitidis or B. burgdorferi.  After 72 hour incubation the animals were sacrificed 
and levels of TNF-α were quantified.  The wild-type mice had statistically significant 
increases in TNF-α upon infection, whereas the NOD2 deficient mice did not (Figure 21).  
These results are consistent with studies conducted by Dr. Vinita Chauhan which 
demonstrate that there are decreased levels of astrogliosis following CNS infection of 
NOD2 deficient mice compared to wild-type (Chauhan et al. 2009).  Taken together our 
studies provide strong evidence that the NOD2 pathway may be an important contributor 
to the generation of inflammation during infection with these pathogens.   Further work 
by Dr. Chauhan and Amy Young, demonstrating decreased demyelination and 
neurological deficit in NOD2-deficient mice as compared to wild-type, indicates that this 
attenuation in inflammation also corresponds to a similar reduction in behavioral and 
pathological manifestations of CNS damage (Chauhan et al. 2009).   
These findings are consistent with the known role for NOD2 in the initiation 
and/or progression of bacterially induced inflammation.  NOD2 mutations have been 
associated with the development of chronic inflammatory bowel diseases and 
monocytes/macrophages derived from humans or mice with such mutations demonstrate 
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altered NF-kB activity and inflammatory cytokine production (Hugot et al. 2001; Ogura 
et al. 2001a; Maeda et al. 2005; Beynon et al. 2008).   
The final section of this study represents a departure from investigations of 
bacterial infections with an examination of the interactions between glial cells and 
viruses.  Vesicular stomatitis virus is a well established model of other neurotropic 
viruses present in the order Mononegavirales.  Infection with this virus results in acute t-
cell independent encephalitis, breakdown of the blood-brain barrier, and a high mortality 
rate similar to that observed during rabies (Frei et al. 1989; Huneycutt et al. 1993).  The 
nature of this infection suggests a possible role for resident CNS cells in the initiation 
and/or progression of the disease state.  Studies have demonstrated that microglia and 
astrocytes can perceive and respond to VSV of the CNS (Bi et al. 1995).  These cell types 
utilize pattern recognition receptors as a means by which to accomplish this.  Previous 
work by members of our research group has demonstrated that microglia and astrocytes 
constitutively express members of the Rig-like helicase receptor family, specifically Rig-
I and MDA5.  Studies have implicated Rig-I as being potentially important in the 
inflammatory responses to VSV infection (Furr et al. 2008).  Studies in our lab have 
shown this receptor to be upregulated following exposure to VSV, suggesting that it may 
play a role in the perception of this virus by microglia and astrocytes (Furr et al. 2008).  
Rig-I serves as an intracellular receptor for replicative RNA virus motifs and is only 
activated following infection of the cell with an actively replicating virus (Meylan and 
Tschopp 2006; Takeuchi and Akira 2007).  Therefore, in order for the Rig-I pathway to 
be utilized by microglia and astrocytes during CNS infection, these cells must be actively 
infected by the virus.  While studies have demonstrated that neurons are readily infected 
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by VSV, the susceptibility of microglia and astrocytes has not yet been evaluated (Bi et 
al. 1995).   
In the current study we examined the permissibility of microglia and astrocytes to 
infection and replication by VSV.  In order to do this we have employed a recombinant 
strain of VSV containing the GFP gene.  Due to the negative-sense polarity of the VSV 
RNA genome and the distant position of the GFP gene from the 3’-end of the genomic 
RNA, GFP expression is only detectable following successful VSV-GFP replication 
within target cells.  Following incubation with the VSV-GFP, GFP expression was 
readily observed in both microglia and astrocytes.  This expression was confirmed using 
immunoblot analysis against GFP and VSV structural proteins.  Since GFP can only be 
produced by successful viral replication, it can be concluded that murine microglia and 
astrocytes are permissive to VSV infection.  Additional studies were conducted utilizing 
a GFP expressing Sendai virus, a non-neurotropic member of the order Mononegavirales 
to examine if this permissibility can be extended to other viruses of this order.  Once 
again GFP expression was readily observed and was confirmed using immunoblot against 
GFP.  Thus we were able to conclude that not only are microglia and astrocytes 
permissive to VSV infection and replication, but that this observation can be extended to 
other members of this order.  This is consistent with the observation that microglia and 
astrocytes are permissive to rabies virus, which is also a member of order 
Mononegavirales.  We also evaluated the permissibility of microglia and astrocytes using 
an established in-vivo model of VSV infection.  As shown in Figure 27B, VSV structural 
proteins were observed both in whole brain isolates as well as purified glial isolations.  
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Additional analysis of the purified glial isolation using FACS demonstrated the presence 
of dual-positive CD11b/GFP cells, indicative of infected microglia.   
We continued our study by characterizing the cytokine responses of microglia and 
astrocytes to VSV infection.  As expected, infection with VSV resulted in the production 
of significant levels of the pro-inflammatory cytokines Il-6 and TNF-α.  In response to 
SeV microglia and astrocytes also produced significant levels of IL-6 and TNF-α, 
although these levels were approximately 10-fold lower than those observed in response 
to VSV.  This is likely due to species specific differences between VSV and SeV, which 
is expected due to the non-neurotropic nature of SeV.  If indeed the Rig-I pathway is 
responsible, at least in part, for the inflammatory actions of microglia and astrocytes 
following viral infection we would expect these responses to be dependent upon the 
active replication of the virus.  In order to test this hypothesis we exposed microglia and 
astrocytes to heat-inactivated VSV, which are unable to infect or replicat within these 
cells.  The result of this experiment was a 10-fold reduction in the levels of IL-6 and 
TNF-α production.  This is suggestive that active replication is required for optimal 
immune response by microglia and astrocytes.  In order to confirm this, we infected our 
cells with a replication impaired VSV strain (Grdzelishvili et al. 2005; Grdzelishvili et al. 
2006).  Once again a 10-fold reduction in cytokine production was observed.  This 
provides important supporting evidence of possible Rig-I involvement in the anti-viral 
responses of microglia and astrocytes.  It is important to note that this evidence is far 
from definitive and additional experimentation is required in order to demonstrate the 
role of Rig-I in microglia and astrocytes.   
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 In summary, the current study provides definitive evidence of functional NOD2 
pathway expression in murine microglia and astrocytes.  Additionally we also provide 
strong evidence that this pathway may serve an important role in the generation of 
potentially damaging inflammation by resident glial cells within the CNS in response to 
bacterial infection.  Our viral study demonstrated the permissibility of microglia and 
astrocytes to VSV infection.  Additionally, our study highlights the possible replication 
dependent nature of glial responses to VSV, which may indicate a role for recepto s such 
as Rig-I.  Taken as a whole, this research strongly suggests a role for intracellular pattern 
recognition receptors as an underlying mechanism for the generation of inflammatory 
responses by glial cells to CNS pathogens.   
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